University of Nebraska Medical Center

DigitalCommons@UNMC
Theses & Dissertations

Graduate Studies

Fall 12-15-2017

Transcriptome Profiling of Cleft Palate inTGF-beta3 Knockout
Mice Alleles: RNA-SEQ Analysis of TGF-beta3 Mice
Kelsey White
University of Nebraska Medical Center

Follow this and additional works at: https://digitalcommons.unmc.edu/etd
Part of the Bioinformatics Commons, and the Developmental Biology Commons

Recommended Citation
White, Kelsey, "Transcriptome Profiling of Cleft Palate inTGF-beta3 Knockout Mice Alleles: RNA-SEQ
Analysis of TGF-beta3 Mice" (2017). Theses & Dissertations. 239.
https://digitalcommons.unmc.edu/etd/239

This Thesis is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has
been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC.
For more information, please contact digitalcommons@unmc.edu.

TRANSCRIPTOME PROFILING OF CLEFT PALATE IN TGF-3 KNOCKOUT MICE
ALLELES: RNA-SEQ ANALYSIS OF TGF-3 MICE

By

Kelsey Marie White, D.D.S.

A THESIS

Presented to the Faculty of
the University of Nebraska Graduate College
in Partial Fulfillment of Requirements
for the Degree of Master of Science

Medical Sciences Interdepartmental Area
Graduate Program
(Oral Biology)

Under the Supervision of Ali Nawshad, Ph.D.

University of Nebraska Medical Center
Omaha, Nebraska
December, 2017

Advisory Committee:
Peter Giannini, D.D.S., M.S

Ali Nawshad, Ph.D.

S. Prem Premaraj, B.D.S., M.S., Ph. D. FRCD(C)

Hasan Otu, Ph.D.

i
ACKNOWLEDGEMENTS
First, I would like to sincerely thank my leader and mentor, Dr. Ali Nawshad, for the
opportunity to work with and learn from him. Dr. Nawshad has provided me with every
opportunity to maximize my understanding of biological mechanisms and experimental design.
He devoted valuable lab resources and hours of his time to my success. For his unwavering
support during this journey, I am forever grateful.
I would also like to thank irreplaceable members of the research team Jingpeng Liu and
Dr. Hasan Otu. Jingpeng spent much of his time, although he had little, teaching me laboratory
techniques and helping execute lab work. Jingpeng, thank you so much for your guidance and
willingness to support me in this project. Dr. Otu also dedicated the time and resources of his
team to the bioinformatics of this project. Dr. Otu and his team spent countless time teaching me
bioinformatics and how to navigate the information at hand. I sincerely thank him and his team
for their immense knowledge and willingness to teach me.
To Dr. Prem Premaraj, thank you so much for never losing faith in me during this
journey. You have provided your time and support in every research idea and path I took. I am
sincerely grateful for all of the knowledge you instilled in me and the atmosphere you created for
my success both academically and clinically.
I would like to thank Dr. Peter Giannini for also joining me on this journey. I appreciate
your help, support, and willingness to serve on my committee. Thank you for your continued
commitment to the success of our department and residents.
To Mrs. Marian Schmid, thank you for devoting your energy to the proper care and
handling of the animals involved in this project.
To my fellow residents, I owe you all for your endless support in every aspect of
residency. I could never have enough words for how grateful I am for all of you.

ii
Finally, my most sincere gratitude to my family. To my parents, Scott & Sandy, for
helping me get here and to both my parents and in-laws Bob & Susan for supporting our family in
this journey. I could not have done it without you all. To my husband, Scott and son, Briggs,
you guys are my world. Your unparalleled love and support has allowed me to achieve my
dreams—and for this I am eternally grateful.

TRANSCRIPTOME PROFILING OF CLEFT PALATE IN TGF-3 KNOCKOUT MICE
ALLELES: RNA-SEQ ANALYSIS OF TGF-3 MICE
Kelsey M. White, D.D.S., M.S.
University of Nebraska, 2017

Background: Orofacial clefts are the most common craniofacial birth defect with a complex,
combinatorial etiology. Tgf-3 regulates palatal fusion in mice; Tgf-3 knockout mice have cleft
palate (CP) lacking other major deformities. The genes downstream of Tgf-3 during palatogenesis
remain largely unexplored. Our objective was to analyze the global transcriptome changes and
their contribution to CP and identify novel Tgf-3 associated genes involved in formation of CP.
We used RNA-sequencing to analyze and compare the whole transcriptome of Tgf-3 alleles during
palatal growth and fusion in mice.
Results: The whole transcriptome analysis of Tgf-3 mice (C57BL/6) alleles revealed over 6000
significantly differentially expressed genes from 14.5 and 16.5 days post coitum (dpc), in wild type
(WT) and homozygous (HM) genotypes. A majority of differentially expressed genes were
upregulated (WT=2421; HM=3153) compared to downregulated (WT=1694; HM= 2151) over
time. With a 2.0 fold-change cut-off, downregulated genes decreased dramatically (WT=134,
HM=191) compared to upregulated genes (WT=1675; HM=1936).

Comparatively, gene

expression differences between WT and HM were minimal. Using Ingenuity® Pathway Analysis
(IPA) we identified genes which may function as primary contributors to the development of CP.
Conclusions: Using RNA-seq analysis, we provided a global analysis of transcriptome changes
between and within WT and HM in the Tgf-3 mouse model system at critical stages of palate
development. We identified genes that likely play key regulatory roles during palatogenesis
downstream of Tgf-3 bolstering our knowledge of CP.
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CHAPTER 1: REVIEW OF LITERATURE
1.1 Introduction
One in every thirty-three babies born in the United States has a birth defect; birth defects are a
leading cause of infant mortality and lifelong disability. Orofacial clefts are the most commonly
treated craniofacial defect in the pediatric hospital setting with a lifetime cost estimated at
approximately $100,000 (Jugessur et al., 2009). According to national prevalence estimates, cleft
lip with or without cleft palate is the second most common defect with a prevalence ranging from
1/500 to 1/2500 based on geographic origin, racial and ethnic background, and socioeconomic
status (Schutte & Murray, 1999, Parker et al., 2010). Both the financial burden and prevalence of
orofacial clefts warrant investigation into the underlying cause of the deformity with the goal of
improving prevention, treatment, and prognosis for affected individuals.
Orofacial clefts are a congenital disruption to facial structure. In addition to the notable
facial deformity, orofacial clefts cause difficulty feeding, speaking, hearing, and socially interacting
requiring highly-coordinated, interdisciplinary care throughout life. Treatment including surgery,
dental treatment, speech therapy and psychosocial intervention start as early as ten weeks of age
and continue through adulthood (Dixon et al., 2011). The causes of orofacial clefts are a complex
combination of genetic and environmental factors lending to difficulty in fully understanding the
role of genes and the environment in this embryological disturbance (Schutte & Murray, 1999).
Previous research has identified several genes that play significant roles in palatogenesis, such as
TGF-3, and are likely implicated in cleft palate formation (Dixon et al., 2011).
Members of the TGF family play crucial roles in facial development as demonstrated in
several studies. The Tgf-3 knockout mouse model results in the phenotype of cleft palate. In
chickens where the palate is normally cleft, exogenous Tgf-3 has been shown to induce palate
fusion (Sun et al., 1998). Further, various authors have confirmed that mutations involving TGF-
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3 are associated with cleft palate in humans (Zhu et al., 2012b). Research continues to show that
TGF-3 is fundamentally important in successful palate development; however we have yet to
completely explore the biological mechanisms downstream of TGF-3. A complete gene analysis
of Tgf-3 mouse alleles will allow us to elucidate genes under control of TGF-3 in proper palate
formation and those in the knockout model implicated in cleft formation.
1.2 Orofacial Clefts
Reported prevalence of orofacial clefts varies worldwide; orofacial clefts occur in
approximately one in 700 live births. Prevalence in gender and sidedness also differ with 2:1 male
to female ratio in cleft lip, 1:2 male to female ratio in cleft palate, and 2:1 ratio of left to right sided
clefts (Dixon et al., 2011). Incidence is greatest in American Indians followed by Asians,
Europeans and least in African Americans (Panamonta et al., 2015).
Orofacial clefts have varying degrees of phenotypic presentation as shown in Figure 1. Cleft
lip can present with or without cleft palate (CL/P) or the cleft can be confined to the palate only
(CPO) (Dixon et al., 2011). Orofacial clefts can occur as part of a syndrome—approximately 30%
of CL/P and 50% of CPO cases are syndromic and a result of chromosomal anomalies, Mendelian
syndromes, or teratogenic exposure. A majority of orofacial clefts are non-syndromic, having no
other associated anomalies. These categorizations lend to four specific groups of clefts: syndromic
CL/P, syndromic CPO, non-syndromic CL/P, and non-syndromic CPO (Schutte & Murray, 1999).
Accurate identification of phenotype is crucial in understanding underlying genetic etiology in nonsyndromic CL/P and CPO. Various presentations clinically reflect genetic heterogeneity. New
studies suggest that phenotypic presentation is a more complex spectrum including minor structural
variants such as lip pits, dental anomalies, defects of the orbicularis oris muscle, and speech or
cognitive differences. Palatal variants can include a bifid uvula or submucous cleft. Accurate
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phenotyping could lend to more evidence in twin studies and familial clustering studies (Dixon et
al., 2011).
The complex, heterogeneous etiology of orofacial clefts involves several environmental
teratogens and a multitude of genes. Noted teratogens, such as smoking, increase risk of orofacial
clefts by as much as 6% (Beaty et al., 2006). Additionally, certain drugs, maternal alcohol use, and
pesticides have the ability to disrupt normal facial development during embryogenesis resulting in
a cleft. Epidemiological studies of indigent populations suggest that both socioeconomic status
(SES) and maternal nutrition are risk factors of orofacial clefts; the prevalence of orofacial clefts is
higher in populations of lower SES. In these populations, it is difficult to separate the risk
contribution of SES and maternal nutrition; however, it is suggested that environmental factors are
responsible for as much as one-third of orofacial cleft cases in indigent populations (Schutte &
Murray, 1999). While the environment has notable effects on palate development, the genetic
component of cleft palate (CP) is being aggressively studied.
Genetic perturbations have been associated with orofacial clefting through family, twin, and
epidemiologic studies (Spritz, 2001). According to a population study in Norway, first-degree
relatives (parents, full siblings, and offspring) have a 32 time higher risk with CL/P and 56 time
higher risk with CPO. Relatives of patients with non-syndromic CL/P have an increased risk of
recurrence; with the decreasing degree of relationship, the risk also decreases (Spritz, 2001).
However, a family with numerous individuals affected is rare, suggesting that the defect is likely a
result of a combination of multiple genes with additive risk, as well as its previously suggested
environmental contribution. Similarly, studies involving monozygotic twins confirm that the
etiology of orofacial clefts is a result of both genetic and environmental components. Concordance
of monozygotic twins, 47%, was significantly greater than that of dizygotic, 8%--a purely genetic
epidemiology would result in 100% concordance in monozygotic twins (Beaty et al., 2006).
Research continues to uncover genetic factors contributing to cleft formation.
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One major modality of research focuses on the genetic components of syndromic forms of CP.
Even though CP lacks a true Mendelian inheritance pattern, studies rely on exploration of
syndromes including cleft palate since underlying mechanisms of cleft formation may be similar
(Iwata et al., 2011). X-linked cleft palate and Van der Woude syndrome are two examples of
syndromes with similar phenotypic presentation to orofacial clefts (Schutte & Murray, 1999).
Further assessment of the etiology of orofacial clefts will improve our understanding of the facial
deformity and include genetic and environmental risk assessment applicable for genetic counseling
and prevention (Dixon et al., 2011). Genetic linkage and association studies are conducted to
identify loci and genes responsible for orofacial clefts. Due to low numbers of families and high
heterogeneity, loci have not been consistently identified among studies. Human genes with
identified association include TGF-3 (Murray, 2002). The TGF isoforms have been shown to
be intricately involved in palate fusion warranting a thorough investigation of their role and
downstream effects.

5

Figure 1. A) Illustrations of different types of orofacial clefts; a and e show unilateral and
bilateral clefts of the soft palate; b, c and d show degrees of unilateral cleft lip and palate; f, g,
and h show degrees of bilateral cleft lip and palate (Dixon et al., 2011).
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1.3 TGF-3
Transforming growth factor-3 (TGF-3) belongs to the  growth factor superfamily
consisting of more than 30 ligand proteins, signaling through Smads or MAPKs (Zhu et al., 2012b,
Nawshad et al., 2004). This gene family is involved in biological activities that control cell
proliferation, migration and differentiation; regulate extracellular matrix deposition; and promote
epithelial-mesenchymal transformation (EMT). The three isoforms—1, 2, 3—are highly
conserved between species with 71-76% sequence identity and have distinct spatial and temporal
expression (Zhu et al., 2012b). Further, phenotypes resulting from knockouts of each TGF
isoform are distinct and cannot be compensated by other family members. Mutations of Tgf-1 in
mice do not survive beyond 11 dpc and cannot be evaluated for palatal involvement; Tgf-2
knockout mice have defects of the maxilla and mandible with only 23% having cleft palate; and
Tgf-3 knockout mice show cleft palate only with 100% penetrance (Nawshad et al., 2004).
The TGF isoforms have shown to be spatially and temporally distinct. As shown in mouse
palate development, Tgf-1 is involved in both epithelial and mesenchymal tissues, Tgf-2 is
mainly in mesenchymal tissues, and Tgf-3 is expressed in medial edge epithelium (Ichikawa et
al., 2006). Further, Tgf-3 appears to be solely responsible for fusion of palatal shelves regulating
periderm sloughing and EMT of the medial edge epithelium (Nawshad et al., 2004, Hu et al.,
2015a).

1.4 TGF-3 Signaling and Downstream Molecules
Well-coordinated processes including cell migration, apoptosis, cell morphology, cell cycle
progression, growth, and proliferation are essential for proper palate formation. Palatogenesis
occurs in four main steps: vertical shelf growth, elevation, adhesion, and fusion (Zhu et al., 2012b).
As shown in mouse models, Tgf-3 is essential for palate fusion. Additionally, in vitro inhibition
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of Tgf-3 activity resulted in failure of palatal fusion of organ cultures.

Tgf-3 has also been

shown to rescue palatal fusion in Tgf-3 knockout mice (Meng et al., 2009).
The TGF isoforms are uniquely able to signal via multiple pathways including SMAD, G
protein/MAPK, and PI3 kinase with divergent signaling outcomes (Nawshad et al., 2005). In the
SMAD-dependent pathway, illustrated in Figure 2, the TGF ligands signal through
serine/threonine kinase receptor complexes TGF type I receptor (TrI) and TGF type II receptor
(TrII). TGF ligand first binds to TrI; TrI becomes phosphorylated and active with the binding
of the ligand (Jugessur et al., 2009).

The TrII is recruited to the complex forming a

heterotetrameric signaling complex. This complex is internalized into an early endosome and
receptors are recycled back to the membrane. In the early endosome, protein SMAD anchor for
receptor activation (SARA) modulates the interaction of SMAD2/3 to TGF receptors forming
TGFIr/SARA/SMAD2 or 3 complex (Nawshad et al., 2005). Phosphorylation of SMAD2 and/or
SMAD3 allows association with SMAD4; SMAD4 ushers the complex into the nucleus for
transcriptional activation or repression of TGF target genes (Cui et al., 2003). For example, target
gene lymphoid-enhancing factor 1 (LEF1), has been shown to upregulate genes involved in EMT,
an essential component of palatogenesis (Nawshad & Hay, 2003). Both in vivo and in vitro
experiments confirm TGF-mediated SMAD signaling is the major pathway for EMT required for
palate fusion (Nawshad et al., 2004).
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Figure 2. Illustration of Smad-dependent TGF signaling pathway during palatal EMT. TGF-
ligand bind TGF- receptors I and II at the cell surface. After phosphorylation of TGFIr,
receptors internalize with the ligand into a plasma membrane pit forming vesicles and early
endosomes in the cytosol with phosphorylated receptors and ligand attached. Protein SARA
modulates cellular trafficking and transports cytoplasmic Smad2/3 to the TGF- receptors to form
TGFIr/SARA/Smad2 or 3 complexes. Smad2 or 3 is phosphorylated and with help of Smad4
able to enter nucleus ultimately activating EMT genes (Nawshad et al., 2005).
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1.5 Craniofacial Development
Craniofacial development is a complex process that begins at the fourth week in utero.
Craniofacial development relies on migration of cranial neural crest (CNC) cells to guide the
patterning of the face by populating the branchial arches (Chai & Maxson, 2006). The timing and
extent of migration is tightly controlled by highly conserved homeobox genes (Marazita &
Mooney, 2004). Neural crest cells migrate into the developing branchial arches and are the source
of skeletal and connective tissue structures (Alappat et al., 2003).
Development of the face, illustrated in Figure 3, results from harmonized growth and
differentiation of five facial primordia—the medial frontonasal prominence, paired maxillary
prominences, and paired mandibular prominences—surrounding the primitive oral cavity (Alappat
et al., 2003). Both the maxillary and mandibular prominences grow toward each other in the
midline where they will fuse forming the upper jaw and lip and lower jaw and lip, respectively.
The frontonasal process forms the forehead, nose, lip, philtrum and primary palate (Cordero et al.,
2011). Within the frontonasal prominence, nasal placodes form from localized thickenings of the
surface ectoderm eventually forming the nasal pits, lateral and medial nasal prominences (Alappat
et al., 2003). The maxillary prominences fuse with the lateral and medial nasal prominences
bilaterally followed by the intermaxillary segment of the frontonasal process (Alappat et al., 2003).
Failure of the maxillary prominences to fuse with the medial nasal prominence on one or both sides
can result in a unilateral cleft lip or bilateral cleft lip, respectively (Alappat et al., 2003).
Palatogenesis begins during week five and continues through week twelve forming the primary
and secondary palates (Chai & Maxson, 2006, Lan et al., 2015). The primary palate is anterior to
the incisive foramen and consists of the philtrum, incisors, and a small portion of the hard palate.
Located posterior to the incisive foramen, the secondary palate begins formation at week six of
embryogenesis creating the majority of the hard palate and entire soft palate. Paired palatal shelves
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start as vertical extensions of the maxillary processes on either side of the tongue. The developing
lower jaw allows the tongue position to lower during the eighth week and the palatal shelves to
elevate into a horizontal position. The palatal shelves grow towards each other fusing with the
primary palate anteriorly, nasal septum dorsally, and each other at the midline. When the palatal
shelves adhere in the midline, the periderm covering the medial edge epithelium (MEE) must be
eliminated first to allow the epithelial cells to fuse forming the midline epithelial seam (MES) (Chai
& Maxson, 2006, Lan et al., 2015). Although the mechanism is yet to be fully elucidated, MES
cells have three possible fates to produce a confluent palate: EMT, apoptotic cell death, or migration
of MES cells to oral or nasal sides of the palate (Nawshad, 2008, Lan et al., 2015). Any disruption
of palatal shelf growth, elevation, or fusion can result in a CP (Lan et al., 2015). Palatal clefts can
include one or more of the following: hard palate, soft palate, and uvula (Cordero et al., 2011).
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Figure 3. Schematic diagram of development of the face and palate in humans; a) Developing
frontonasal prominence, paired maxillary and mandibular processes with primitive oral cavity by
the fourth week of embryogenesis; b) Formation of nasal pits leading to paired medial and lateral
nasal processes by week five; c) Medial nasal processes and maxillary processes merged forming
the upper lip and primary palate by the sixth week of embryogenesis; d) Palate formation
beginning at week six as bilateral outgrowths from the maxillary processes on either side of the
tongue; e) Palatal shelf horizontal elevation and contact; f) Palate fusion (Dixon et al., 2011).
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1.6 Mouse Model System
Animal models have significantly improved our understanding of the genetic activity in
palatogenesis. Over 200 genetically mutated mice exhibit CP phenotype (Iwata et al., 2011).
Palatogenesis is remarkably similar in humans and mice providing an ideal model system to assess
the role of particular genes in orofacial deformity (Nawshad et al., 2004, Chai & Maxson, 2006).
Several mouse strains with CP are available; Msx1, Tgf-3, and Ap-2 knockouts are three examples
that result in cleft phenotype (Dixon et al., 2011, Schutte & Murray, 1999). Several studies have
confirmed the essential role of Tgf-3 in mouse palatogenesis; Tgf-3 mice have CP due to failed
palatal shelf fusion with the absence of any other craniofacial deformity (Nawshad et al., 2004).
The mouse is an ideal animal for the study of palatogenesis being both time- and costeffective with several offspring—a litter produces approximately 8 pups. Mice have a short
gestation period of 21-22 days with palatogenesis occurring from day 11-16dpc coordinating with
human development weeks 6-12 in utero (Rabadan-Diehl & Nathanielsz, 2013). Palate formation
in mice, illustrated in Figure 4, begins at 11.0-11.5dpc. Tgf-3 is detected throughout palate
development in MEE. After vertical growth is complete, palatal shelves elevate at 13.0-13.5dpc.
Palatal shelves will grow towards each other and begin to contact at 14.0-14.5dpc. Tgf-3 is found
in the greatest quantity at the MEE during EMT and will persist until cells complete the
transformation. By 16.0-16.5dpc, palatal fusion has occurred (Nawshad et al., 2004). The use of
animal models, particularly mice, with CP has allowed the discovery of both cellular and molecular
mechanisms of palate formation.
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Figure 4. A-C: Camera lucida drawings of paraffin sections of the developing rodent palate; a)
Between 13 and 14dpc palatal shelves move horizontally towards each other above the tongue
during which the periderm layer sloughs off the epithelium along the medial palatal edge (p); b)
Epithelial seams transform to mesenchyme to become confluent between 15 and 17dpc; c) Palate
shelves fuse together with nasal septum (ns); D-G: Hematoxylin and eosin-stained sections of
rodent palates fixed at different stages in palatogenesis in vitro; d) palatal shelves in contact with
palatal seam (white arrow); e) seam disintegration; f) continued seam disintegration; g) palate
fusion with complete confluence (blue arrow) (Nawshad, 2008).
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1.7 Conclusion
Non-syndromic CL/P and CP have been extensively studied. The causes of orofacial clefts are
incredibly sensitive to environmental disturbances, making it difficult to identify and understand
gene-gene and gene-environment interactions (Schutte & Murray, 1999). The high prevalence of
orofacial clefts and their devastating malformations continues to drive research to find precise
genetic causes and targets for prevention.
Several studies have confirmed that TGF-3 is paramount to palatal fusion in both primary
cells and organ culture. While we know TGF-3 is a candidate gene for non-syndromic CP in
humans, we still have yet to fully explore genes that are directly regulated by TGF-3 in both
normal palate formation and CP (Ozturk et al., 2013). In conclusion, the ability to provide an
analysis of Tgf-3 and its downstream signaling effects during palatogenesis in a mouse model can
provide a deeper knowledge of the development of CP and the genes involved.
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CHAPTER 2: OBJECTIVE AND AIMS OF THE STUDY

2.1 Objective and specific aims
The objective of this study was to analyze transcriptome changes and their contribution to
the development of cleft palate at gestational ages 14.5dpc and 16.5dpc in Tgf-3 knockout mice
alleles. The specific aims of this project were to:


Using RNA-sequencing we will create a genome scale analysis of the palatal
transcriptome of Tgf-3 WT and HM mice at critical stages of palatogenesis (14.5 and
16.5dpc).



Our RNA sequencing data will show a comprehensive analysis of Tgf-3 signaling
effects during palatogenesis and genes subsequently altered in mutants causing palatal
cleft.



Our genome scale analysis of the palatal transcriptome will identify exact functional
cellular changes that are active during palatogenesis and compromised in Tgf-3 HM
palates.

2.2 Hypothesis
We hypothesize that there will be a differential expression of novel genes between Tgf-3
WT and HM mice at different time points critical to palate development (14.5 and 16.5dpc)
that are specific for causing cleft phenotype.
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CHAPTER 3: MATERIALS AND METHODS

3.1 Introduction
This chapter describes the materials and methods used to analyze the transcriptome
changes of Tgf-3 mice using RNA-sequencing at critical stages in palatal development. While
substantial evidence shows the importance and role of TGF-3 in palatal fusion and its implication
in CP, we do not know what cellular pathways are directly or indirectly regulated by TGF-3 during
palatogenesis.
The purpose of this study is to enhance our knowledge of the role of TGF-3 in normal
palatogenesis and in formation of a cleft by exploring the differentially expressed genes at 14.5 and
16.5dpc in a mouse model. Our particular interest is any gene up-regulated or down-regulated in
the Tgf-3 WT versus HM alleles. We then hope to define the involvement of dysregulated genes
in the cellular mechanisms underlying palatogenesis improving our knowledge of downstream
effects of TGF signaling. Results from such analysis will identify new candidate genes that may
aid in our attempt to fully elucidate the mechanism underlying this orofacial deformity.
3.2 Animal Selection and Breeding
Tgf-3 heterozygous (+/-) C57BL/6J male and female mice were provided by Tom
Doetschman (BIO5 Institute, University of Arizona, AZ). This specific mouse strain, C57BL/6J,
has an increased susceptibility to teratogen-induced CP, making this strain ideal. Mice were kept
in accredited animal facilities at the University of Nebraska Medical Center (UNMC) and all
procedures were approved and in accordance with the Institutional Animal Care and Use
Committee (#06-064) of UNMC.
To produce heterozygous offspring for mating, a replacement type targeting vector was
made with exon 6 of the Tgf-3 gene replaced by neomycin-resistance gene derived from the
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pMC1neo vector. E14-1ES cells were transfected with the targeting vector with correct targeting
found in 5/250 neomycin-resistant clones analyzed by Southern blot analysis. Genomic DNA was
prepared and injected into C57BL/6 blastocysts and mated.

Heterozygous offspring were

confirmed with Southern blot analysis. To produce HM (-/-) Tgf-3 mice, heterozygous mice were
bred. Litters contained approximately 25% homozygous pups as expected from Mendelian
inheritance ratio (Proetzel et al., 1995).
3.3 Dissection and Collection of Palatal Shelves
In pregnant female mice, the morning the vaginal plug was pulled was considered 0.5dpc.
Pregnant female mice were euthanized by CO2 asphyxiation at 14.5 and 16.5dpc. Upon dissection,
embryos were placed in Hank’s Balanced Salt Solution (SIGMA-Aldrich, St. Louis, MO) to
stabilize the embryos. The embryos were dissected in sterile conditions under the Nikon SMZ1000
stereomicroscope system (Nikon, Tokyo, Japan); palatal shelves and tails were collected from 510 embryos per pregnancy (Figure 5). Palatal tissues were stored in Invitrogen

TM

RNAlaterTM

Stabilization Reagent (Qiagen, Hilgen, Germany) to preserve the gene expression profile. Samples
were labeled to correspond to tail tissue used for genotyping.

18

A

B

C

Figure 5: Process of palatal shelf extraction. a) Sterile laboratory dissection conditions; b)
Embryonic pups from E16.5 pregnant female mouse; c) Palatal cleft in E16.5 pup.
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3.4 Genotype Confirmation
Embryonic genotyping was confirmed using PCR followed by gel electrophoresis. Tissue
samples, embryonic tails, were isolated from embryos at 14.5 and 16.5dpc. Genomic DNA was
prepared using the Gentra Puregene Tissue Kit (Qiagen, Hilden, Germany). DNA concentration
was confirmed using the NanoDrop 2000c spectrophotometer (NanoDrop, Wilmington, DE). Tgf-

3 genotyping primers were attached to individually labeled tissue samples as follows:
TGF-3 Forward 5’ TGG GAG TCA TGG CTG TAA CT 3’
TGF-3 Reverse 5’ CAC TCA CAC TGG CAA GTA GT 3’
These primers amplified 1200bp and 400bp for HM and WT alleles, respectively shown in Figure
6. PCR conditions were one cycle of 95ºC for 1.5 minutes followed by 35 cycles of 95ºC for 30
seconds, 57ºC for 50 seconds, 72ºC for 1.5 minutes, and ended with one cycle of 72ºC for 5 minutes.
Fifteen mL of PCR product from each reaction was loaded onto 1% agarose gel. Electrophoresis
was run at a constant 100V, 400mA and 400W for 1 hour and evaluated with Kodak Gel Logic 100
Imaging System (Kodak, Rochester, NY).
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Figure 6: Genotype confirmation using RT-PCR with gel electrophoresis.
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3.5 RNA Extraction and Purification
Total proteins were collected from previously stored palatal shelves of 14.5 and 16.5dpc
pups. RNA was extracted using PicoPureTM RNA Isolation Kit (ThermoFisher Scientific, San
Francisco, CA). Further purification was done use DNase Treament (Qiagen, Hilden, Germany)
as described previously (LaGamba et al., 2005, Zhu et al., 2012a). Purity and concentration were
measured by ultraviolet spectroscopy using the Nano Drop 2000c spectrophotometer (NanoDrop,
Wilmington, DE).
3.6 Preparation of cDNA Library
RNA was sent to University of Nebraska Medical Center Bioinformatics and Systems
Biology Core Facility. Libraries were prepared using Illumina mRNA-Seq Sample Preparation Kit
(Illumina, San Diego, CA) according to manufacturer instructions. Poly(A)+ RNA was recovered
from 1 µg of total RNA using two rounds of hybridization with oligo-dT-cated Sera-Mag magnetic
beads. The recovered poly(A)+ RNA was then chemically fragmented and next converted to cDNA
using SuperScript II and random primers. The second strand was synthesized using RNaseH and
DNA Pol I. The ends of cDNA were repaired using T4 DNA polymerase, T4 polynucleotide
kinase, and Klenow DNA polymerase. A single adenosine was added to the 3’ end using Klenow
fragment (3’ to 5’ exo minus). Adapters were attached to both ends of cDNA using T4 DNA ligase.
RNA fragments were extracted from a 2% low range ultra agarose sizing gel and amplified by 15
cycles of PCR using Phusion® DNA Polymerase (Thermo Fisher Scientific, San Francisco, CA).
Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA) was used to validate libraries. Libraries
were diluted and applied to Illumina flow cell using the IlluminaCluster Station (Illumina, San
Diego, CA) as previously described (Ozturk et al., 2013).
3.7 RNA-Sequencing Analysis & Comparison of Differentially Expressed Genes
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RNA-sequencing (RNA-seq) was conducted using Illumina HiSeq2000 (Illumina, San
Diego, CA) for Tgf-3 (-/-) HM and Tgf-3 (+/+) WT samples profiled at 14.5 and 16.5dpc. RNAseq uses high-throughput sequencing technology providing the ability to investigate RNA content
from sequencing of cDNA and the ability to measure transcript quantity in a single assay (Roberts
et al., 2011, Trapnell et al., 2012). RNA-seq allows the rapid, comprehensive discovery of novel
genes for a reasonable cost; simply, RNA-seq quantifies how often each gene is represented in a
sample (Marguerat & Bahler, 2010). Two independent biological and technical replicates were
assayed at each time point for each both HM and WT to evaluate reproducibility of samples and
procedures resulting in eight (n = 2 x 2 x 2) samples for sequencing performed in 2x101bp pairedend mode. Raw reads were analyzed with FASTQC (v. 0.11.5) for quality control (Andrews, 2010).
Overrepresented sequences, for example those containing adapter or primer sequences, remaining
in the raw reads were assessed and subsequently removed using Timmomatic (v 0.36) in the
palindrome mode based on default alignment detection and scoring parameters (Bolger et al.,
2014). Trimmomatic was also used for low-quality base filtering. Maximum information quality
filtering was employed with a minimum average read quality threshold of 25. Following technical
sequence and low-quality base removal, reads that were shorter than 36bp were removed.
Transcript quantification was done based on the GRCm38.p5 reference genome using Salmon (v.
0.8.2) with default parameters (Patro et al., 2017). Salmon uses sample-specific models such as
correction for GC-content bias that improves the accuracy of transcription abundance estimates.
We use Transcripts Per Million (TPM) in Salmon’s output as the relative abundance measure
employed in our downstream analysis.
3.8 Comparison of Differential Gene Expression
Differential gene expression is evaluated using software tool DESeq2. This program
allows the analysis of read counts per gene based on set parameters, such as required fold-change
(Love et al., 2014). DESeq2 uses a negative binomial model to assess differential expression and
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employs the Benjamini Hochberg procedure for multiple hypotheses testing correction (Benjamini
& Hochberg, 1995). When comparing the transcription abundance between two groups of samples,
we used the adjusted p-value cut-off of 0.05 to define statistically significant differential
expression. RVennDiagram was used to generate highly-customizable, high-resolution Venn
diagrams for each experimental group with a fold change (FC) of 2.0 or greater (Ozturk et al.,
2013). This allows a visual grouping of dysregulated genes by distinct region to compare HM and
WT at two different time points.
Clustering of samples was done using the Unweighted Pair Group Method with Arithmeticmean method using Pearson’s correlation as the distance measure (Sneath, 1973). The expression
data matrix was row-normalized prior to the application of average linkage clustering. The
Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 (Huang da et al.,
2009) was used for functional analysis of the gene lists interrogating Biological Process (BP),
Molecular function (MF), and Cellular Component (CC) Gene Ontology (GO) categories
(Ashburner et al., 2000) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways
(Kanehisa & Goto, 2000a). Biologically relevant categories that are over-represented in the gene
set and therefore may be of further interest were assessed using Expression Analysis Systematic
Explorer (EASE) score in the DAVID tool. The EASE score is the upper bound of the distribution
of Jackknife iterative resampling of Fisher exact probabilities with Bonferroni multiple testing
correction. Categories containing low numbers of genes are under-weighted so that the EASE score
is more robust than the Fisher exact test. The EASE score is a significance level with smaller EASE
scores indicating increasing confidence in over-representation. We selected GO categories that
have EASE scores of 0.05 or lower as significantly over-represented.
3.9 Biological Evaluation and Pathway Analysis
Differentially expressed genes between HM and WT were further analyzed using
Ingenuity® Pathway Analysis (Ingenuity® Systems, www.ingenuity.com) software. Prior to
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uploading data into IPA, a statistical analysis of RNA-seq data was performed. For a gene to be
considered differentially expressed, the adjusted p-value must be less than or equal to 0.05.
Resulting RNA-Seq data Entrez IDs and fragments per kilobase per million mapped (FPKM) values
were entered into IPA. IPA is based on the manual curation of scientific literature to identify
pathways, networks, and functional categories that are significantly represented in the input gene
list.
3.10 Confirmation of Dysregulated Genes with Real-Time PCR
To confirm dysregulated genes between WT and HM samples, quantitative real-time PCR
(qPCR) was performed. Palatal tissues were extracted from embryos at 14.5 and 16.5dpc and RNA
extraction was conducted as previously described using PicoPureTM RNA Isolation Kit
(ThermoFisher Scientific, San Francisco, CA) with DNase Treatment (Qiagen, Hilden, Germany)
used to extract high-quality RNA consistently from very few cells (Zhu et al., 2012a, LaGamba et
al., 2005).

RNA was converted to cDNA using SuperscriptTM IV VILOTM Master Mix

(ThermoFisher Scientific, San Francisco, CA) providing a highly efficient and thermostable reverse
transcriptase allowing significant cDNA yield at high temperatures in less time. An additional preamplification step was conducted using TaqManTM PreAmp Master Mix (ThermoFisher Scientific,
San Francisco, CA) with a custom pre-amplification pool of 32 selected genes of interest to amplify
small amounts of cDNA without introducing amplification bias—specifically for small, precious
mRNA samples—allowing more qPCR reactions. Samples underwent 14 preamplification cycles
were with thermal cycling conditions of 95C for 15 seconds and 60C for 4 minutes followed by
immediate placement on ice. Next, samples underwent 1:20 dilution diluted with TE buffer.
Finally, samples were placed on 96-well custom array plates in technical triplicate and qPCR
executed with TaqMan Fast Advanced Master Mix (ThermoFisher Scientific, San Francisco, CA)
reagents. PCR conditions were 40 cycles at 95C for 15 seconds and 60C for 1 minute.
3.11 Statistical Analysis of Real-Time PCR
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Technical repeat's normalized gene-specific CTCt value were subtracted from the
housekeeping gene CtCt value. Then, data were analyzed using analysis of variance (ANOVA) on
the repeat-normalized CtCt values, including the control group and translate effects estimated
from the ANOVA onto the multiplicative scale. The values of tested 29 genes were normalized by
adjusting for the concentration of abundant known house-keeping genes, like 18SrRNA, GAPDH
and β-actin, and the Ct values of naive/vehicle group. PCR assays detecting the reference genes,
18SrRNA, GAPDH or β-actin calculated alongside those for the gene of interest and the resulting
dataset were analyzed. 18SrRNA, GAPDH, and β-actin are constitutively expressed and were
therefore used as controls in the quantitative analyses.
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CHAPTER 4: RESULTS
4.1 RNA Sequencing Quality Analysis
The bioinformatics analysis of RNA-Sequencing showed raw RNAseq average read counts
of 65.5 million paired-end reads (130.1 million total reads) per sample for the eight sample profiles
(Figure 7a). Average read-length started as 101 base pairs (bp) in raw reads, subsequently reduced
to an average of 95.86bp following trimming and filtering (Figure 7b). Overall average read quality
score increased from 35.84 to 36.79 and the percentage of high quality bases—bases with a quality
score greater than 20—per sample increased from 96.28% to 99.20% following trimming and
filtering (Figure 7c and d). Both the total number of reads and the average read length parameters
showed small changes in quantity, resulting in significant quality improvement after trimming and
filtering.
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Figure 7: (a) The total number of paired-end reads, (b) average read length in base pairs (bp), (c) average read quality,
and (d) % of bp in the ensemble of reads that exceed a quality of score of 20.
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4.2 RNA Sequencing Transcript Quantification
RNA-seq analysis generated expression data for 103,215 transcripts. The transcripts with
a TPM values less than 1.0 in all eight samples (WT14.5a, WT14.5b, WT16.5a, WT16.5b,
HM14.5a, HM 14.5b, HM16.5a, HM16.5b) were eliminated from downstream analysis leaving
52,475 transcripts. Hierarchical clustering of all transcripts reveals that the samples are clearly
separated by time with little effect of genotype warranting a need for supervised analysis methods
to identify the differences in gene expression due to genotypic variance (Figure 8). Further, the
close proximity of branching at 14.5dpc in HM and WT compared to a more distant relationship at
16.5dpc indicates that the samples are more similar at 14.5dpc with growing disparity over time.
Therefore, the effects of Tgf-3 knockout are more pronounced at 16.5dpc.
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Figure 8: Hierarchical clustering of all the samples using all 52,475 transcripts with TPM>1 in at
least one sample group.
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4.3 Differential Expression Analysis
Differential expression analysis showed a significant temporal difference in gene
expression between samples; there were over 4115 significantly differentially expressed genes
(SDEG) between 14.5 and 16.5dpc in WT samples and 5304 SDEGs between 14.5 and 16.5dpc in
HM samples (Table 1). From our transcriptome analysis, a majority of differentially expressed
genes were upregulated (WT = 2421; HM = 3153) compared to downregulated (WT = 1694; HM
= 2151) from 14.5 to 16.5dpc demonstrating that transcriptional induction overshadows
transcriptional silencing between these time points. A fold-change (FC) cut-off of 2.0 was applied
to further define significant differential expression; downregulated differentially expressed genes
decreased dramatically (WT=134, HM=191) compared to differentially expressed upregulated
genes (WT=1675, HM=1936) again emphasizing the difference in upregulated versus
downregulated genes. Venn diagrams were created to illustrate the number of differentially
expressed genes dysregulated from 14.5 to 16.5dpc in WT and HM (FC>2.0) (Figure 9a). By
comparison, the difference in gene expression between genotypes at the same time point was
minimal (HM14.5 vs. WT 14.5 = 13; HM16.5 vs. WT16.5 = 38). Again following trend, the
genotype differences at 14.5dpc are minimal with no gene dysregulated with a FC>2.0 and a greater
difference between genotypes at 16.5dpc and 13 genes dysregulated with FC>2.0. With the
difference in genotype minimal, we defined the effects of Tgf-3 knockout by comparing the
temporal gene expression of WT and HM. Genes significantly dysregulated within each genotype
were termed “WT Specific” (WS, 479+72) and “HM Specific” (HS, 690+129) as depicted in Figure
9a.
Further analysis to demonstrate the functional mechanisms associated with dysregulated
genes between samples from 14.5 to 16.5dpc are highlighted in GO and KEGG pathways that are
statistically significantly enriched among the samples (Figure 9c).
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# of
SDEG

# of SDEG
(|FC| > 2.0)

Up in WT16.5 vs. WT 14.5

2421

1675

Down in WT16.5 vs. WT 14.5

1694

134

Up in HM16.5 vs. HM 14.5

3153

1936

Down in HM16.5 vs. HM 14.5

2151

191

Up in HM 14.5 vs. WT 14.5

8

0

Down in HM 14.5 vs. WT 14.5

5

0

Up in HM 16.5 vs. WT 16.5

30

10

Down in HM 16.5 vs. WT 16.5

8

3

WT
Time
Comparison
HM

14.5
Genotype
Comparison
16.5

Table 1: Significantly Differentially Expressed Genes (SDEG, multiple hypothesis testing
corrected p-value < 0.05) across time and genotype points separately listed for up-/downregulation (FC: fold change).
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Figure 9: (a) Comparison of significantly differentially expressed genes (SDEGs) between E16.5 and E14.5 in the WT
and HM groups. WT Specific-Up (WSU): Genes uniquely upregulated in the WT group at E16.5; WT Specific-Down
(WSD): Genes uniquely downregulated in the WT group at E16.5; HM Specific-Up (HMU): Genes uniquely
upregulated in the HM group at E16.5; HM Specific-Down (HMD): Genes uniquely downregulated in the HM group
at E16.5, (b) Hierarchical clustering of 501 (429+72) WT specific and 819 (690+129) HM specific genes, (c)
Significantly enriched Gene Ontology categories in the WT specific and HM specific gene lists (sample genes in the
groups shown).

33
4.4 Real-Time PCR Confirmation of Dysregulated Genes
Our qPCR data of selected WT and HM genes (Table 2 and 3) supports RNAseq results
using normalized fold-change ratio to our reference control genes—18sRNA, GAPDH, and -actin
(Appendix A). The qPCR data shown in Figure 10 confirms the results of our RNAseq analysis,
demonstrating at 16.5dpc WT palates have a significantly increased expression of Cdh1, Ocln and
F2rl1 and significantly decreased expression of Tnfrsf11b, Fndc3c1, Dlx1, and Gas2 compared to
the endogenous control set (p<0.01). Similarly, in HM palates as shown in Figure 11, qPCR data
confirms RNAseq results showing a significantly increased expression of Chrng, Col2a1,
Coll11a1, Col11a2, L1cam, Adam12, Fas, Hspg2, Lox, Itgb4, Klf5, Cldn1 and Nrcam and
significantly decreased expression of Wnt9b, Alx4, Pax1, Kcp, Msx1, Ppp1r17, Pdgfc, Twist1, and
Wnt5a at 16.5dpc compared to the controls (p<0.01).
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Table 2. Selected dysregulated genes in WT with FC>2.0 (p<0.05).
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Table 3. Selected dysregulated genes in WT with FC>2.0 (p<0.05).
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Figure 10. Fold change (log2) expression of WT gene mRNA relative to reference control
genes (18rSRNA, GAPDH and β-actin). Bar heights indicate mean expression of the genes in
samples. Error bars indicate 95% confidence interval estimates of the mean expressions. One
asterisk indicates statistically significant difference between the means of a sample set compared
to the mean of the control sample set to 5% (correspond to a p-value <0.05); two asterisks indicate
statistically significant difference to 1% (correspond to a p-value <0.01).
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Figure 11. Fold change (log2) expression of HM gene mRNA relative to reference control
genes (18rSRNA, GAPDH and β-actin). Bar heights indicate mean expression of the genes in
samples. Error bars indicate 95% confidence interval estimates of the mean expressions. One
asterisk indicates statistically significant difference between the means of a sample set compared
to the mean of the control sample set to 5% (correspond to a p-value <0.05); two asterisks indicate
statistically significant difference to 1% (correspond to a p-value <0.01).
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CHAPTER 5: DISCUSSION
Orofacial clefting is the most commonly treated craniofacial anomaly in the pediatric
hospital setting (Jugessur et al., 2009). The identification of genetic and environmental causes and
risk factors continues to be at the forefront of current research. Scientific advances allowing more
thorough, sensitive means of gene exploration help identify new mechanisms for embryonic
development and cleft causation with the ultimate goal of converting scientific findings to clinical
care (Jugessur et al., 2009). The development of high-throughput DNA sequencing methods, RNAseq, allows the entire transcriptome to be surveyed quantitatively (Wang et al., 2009).
Bioinformatics analysis was applied to RNA-seq data to identify differentially expressed genes and
functional pathways that may elucidate the biological mechanisms underlying palate fusion.
5.1 Known Cleft Palate Genes
Based on the OMIM and MGI database, current knowledge demonstrates over 300 genes
that, when mutated, cause CP in mice and humans.

The role of TGF-3 gene has been

overwhelmingly established as a crucial molecule that is necessary for normal palate
development—in its absence CP occurs (Ozturk et al., 2013). In this study we focus on the role of
Tgf-3 in the murine model and its associated molecules that are fundamental in normal
palatogenesis. Our study identifies genes that are functionally regulated by Tgf-3; in WT mice
normal palatogenesis sustains whereas, in HM mice, CP results due to altered genes under control
of Tgf-3. Our data reveals that several significantly differentially expressed genes have been
previously identified as CP genes. WT mice showed two specific genes (Twist1, Wnt5a) to be
downregulated significantly at 16.5dpc. HM mice, on the contrary, showed an increased expression
of Chrng, Col2a1, Col11a1, Col11a2, and L1cam genes at 16.5dpc, that play crucial roles in
palatogenesis. We analyzed the specific cellular function, role in palatogenesis, and association
with TGF- signaling pathway of suspected genes using IPA and GeneCards.
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Twist acts as a basic helix-loop-helix transcription factor essential for EMT in both
embryonic development and cancer. Twist is a well-established E-cadherin repressor (Yu et al.,
2008). It has been shown convincingly that EMT is a major mechanism of palatal seam
disintegration – the critical final stage of palate fusion (Nawshad, 2008). Twist is present in the
zone of palatal shelf fusion—indicating its likely importance to palatogenesis.

Further, in

experiments where Twist expression is downregulated, palate fusion is hindered or delayed (Yu et
al., 2008). Conversely, in chicken palates, the addition of Tgf-3 upregulated Twist mRNA
indicating it is downstream of Tgf- signaling (Sun et al., 1998).

Our data confirms that

downregulation of Twist gene in HM inhibits palate fusion resulting in a cleft at 16.5dpc.
Genetic screenings have implicated several isoforms of WNTs—WNT3A, WNT5A,
WNT11—with non-syndromic CL/P (Meng et al., 2009). The WNT signaling pathways are
essential for cell proliferation, differentiation, and survival (Brugmann et al., 2007). Furthermore,
these genes are known to regulate mid-face development, upper lip fusion and are likely associated
with the etiology of orofacial clefts (Brugmann et al., 2007). In situ hybridization studies have
shown Wnt5A expression in the frontonasal prominences and maxillary process which fuse to form
the primary palate (Yamaguchi et al., 1999). Gene interaction studies suggest a variation in
WNT5A regulating neural crest cell differentiation may predispose to an orofacial cleft (Chiquet
et al., 2008).

Specifically, Wnt5a directs cell migration in a graded manner along the

anteroposterior axis of the palate; loss of Wnt5a in mice leads to a complete cleft of the secondary
palate (He et al., 2008). Overall, substantial data demonstrates an essential role of WNT family
members in orofacial growth allowing immaculate fusion of facial primordia. The HM palate
showed a decreased expression of Wnt5a from 14.5dpc to 16.5dpc showing a lack of directional
palatal cell migration and proliferation necessary for both mesenchymal and epithelial homeostasis
resulting in a cleft.
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CHRNG (Cholinergic receptor, nicotinic, ) is a transmembrane receptor for acetylcholine
with five different subunits—two , one , one,  and one . Binding of acetylcholine activates
voltage-gated sodium channels resulting in an action potential in muscle (Hoffmann et al., 2006).
During fetal development, the  subunit is commonly expressed (Kariminejad et al., 2016). The 
subunit is essential for neuromuscular signal transduction connecting axon and muscle; -knockout
is lethal in mice (Hoffmann et al., 2006). In humans, mutations in CHRNG cause Escobar
syndrome and a spectrum of Multiple Pterygium syndromes characterized by several craniofacial
deformities including, but not limited to, cleft palate, joint contractures, pterygia and micrognathia
(Vogt et al., 2012). Current literature shows pterygium is also associated with IRF6 and p63
mutations in humans, which are both known to be associated with TGF-3 pathway (Lihua et al,
2015) (Ozturk et al., 2013). Chrng is upregulated in the HM mice at 16.5dpc indicating that in
absence of Tgf-3 in HM, Irf6 and p63 proteins are differentially expressed resulting in the
persistence of palatal periderm resulting in palatal cleft.
Several types of collagen are variably expressed in the developing palate and essential for
ECM metabolism. Collagen fibers have been shown to contribute to palatal shelf elevation, shelf
adhesion, and ECM formation.

COL2A1 mutations are present in Stickler Syndrome and

chondrodysplasias (Vandenberg et al., 1991, Ahmad et al., 1995). Further, defects in several
collagens—Col1a2, Col2a1, Col11a22, and ColXIa1—are linked to cleft palate (Meng et al., 2009,
Schutte & Murray, 1999). In the HM palate, Col2a1, Col11a1, and Col11a2 were all significantly
upregulated from 14.5 to 16.5dpc suggesting their increased presence in the basement membranes
of persistent, intact palatal epithelia and periderm. Persistence of palatal periderm ultimately
impedes palatal fusion resulting in palatal cleft.
The L1 cell adhesion molecule (L1CAM) is a member of the immunoglobulin gene
superfamily and is associated with a spectrum of disorders collectively known as L1 syndrome. Xlinked hydrocephalus (XLH), Hirschsprung’s disease, fetal alcohol spectrum disorders, and
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carcinomas are some of the variable presentations of L1 malfunction (Schäfer & Altevogt, 2010).
Abnormalities of L1CAM are characterized by severe mental retardation, hydrocephalus, spastic
tetraplegia, bilateral adducted thumbs, and orofacial clefts. Previous literature reports have shown
individuals with XLH who have cleft palate suggesting that L1CAM may contribute to both
phenotypes (Okamoto et al., 2004). While the mechanisms underlying L1cam function are still
elusive, it is generally involved in cell proliferation, adhesion and migration as well as critical in
the development of carcinomas. Based on these data, we propose that L1cam in HM is involved in
maintaining palatal epithelia and periderm attachment and integrity which results in cleft palate.
5.2 Genes Upregulated at 16.5dpc vs. 14.5dpc in Homozygous Palates
The TGF- family members are integral to palatogenesis and responsible for an array of
functions required for palate fusion—cell migration, EMT, ECM synthesis and deposition,
degradation of basement membrane, cell proliferation and apoptosis. In HM mice, Tgf-1 and Tgf-

2 are expressed in MEE cells and mesenchymal cells respectively (Nawshad et al., 2004). Several
upregulated genes in HM mice are under control of other TGF isoforms: Adam12, Clu, Fas,
Hspg2, Cldn1, Lox, Itgb4, and Klf5. These genes, regulated by Tgf-1,2 in HM may regulate
multiple cellular functions essential to proper palatal growth in HM but are unrelated to palatal
fusion, which is a unique characteristic of cleft palate in Tgf-3 knockouts.
Disintegrin metalloproteases, ADAMs, regulate key cellular processes such as apoptosis,
proliferation, and cell adhesion. ADAMs family members have been shown to be under the control
of TGF- signaling showing changes in regulation at the gene expression level (Ramdas et al.,
2013). In the developing HM mouse palate, Tgf-1 and Tgf-2 are expressed in both palatal
epithelia and mesenchyme (Nawshad et al., 2004). The upregulation of Adam12 in the HM palate
at 16.5dpc is indicative of its control by different isoforms of Tgf- necessary for the attainment of
palatal growth and elevation, but not fusion, which is regulated by Tgf-3.
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Clusterin (Clu) is a multifunctional glycoprotein that has a role in epithelial cell
differentiation, cell-cell adhesion, and regulation of apoptosis (Itahana et al., 2007). Clu is
synthesized by cells of epithelial and mesenchymal origin; synthesis is upregulated in tissues
undergoing remodeling or injury exerting a protective function in a stressed environment. Tgf-1
was shown to increase expression of Clu in various cell types: nervous tissue, astrocytes,
fibroblasts, lung epithelial cells, aortic endothelial cells and in HeLa cells in culture (Wegrowski et
al., 1999). The upregulation of Clu at 16.5dpc in HM palatal tissue is a result of induced expression
by isoform TGF-1 suggesting Clu plays no role in palatal fusion resulting in cleft palate.
Apoptosis is essential for embryogenesis, particularly in tissue and organ development and
tissue homeostasis. Fas is a member of the TNF receptor superfamily and a well-known mediator
of apoptosis (Goldthorpe et al., 2015). It has been suggested that Tgf- induces resistance to
apoptosis in lung fibroblasts through suppression of Fas via miR-29 (Matsushima & Ishiyama,
2016). In the HM palate, Fas is upregulated at 16.5dpc induced by other Tgf- isoforms or proapoptotic factors contributing to palatal cell death that is essential in palatogenesis.
Perlecan (Hspg2) is a proteoglycan that is a key component of basement membranes and
ECM. An absence of Hspg2 in mice and humans causes lethal chondrodysplasia (Hara et al., 2017).
Hspg2 has a roles in cell adhesion, proliferation, and angiogenesis.

Tgf-1-induced Hspg2

deposition has been demonstrated in COPD airway smooth muscle (Ichimaru et al., 2012). We
propose that Hspg2 is functional in palatal mesenchyme under the control of Tgf-1 regulating
palatal mesenchymal ECM necessary for palatal growth in HM mice, but without any implication
in palatal fusion.
Claudin-1 (Cldn1), a transmembrane protein localized to the surface of epithelial cells, is
crucial for formation and function of tight junctions (Zhang et al., 2016). Disruption of tight
junctions has been shown to lead to the induction of EMT in cancers with a subsequent loss of cell-
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cell contacts (Katayama et al., 2017). It has also been demonstrated that Tgf-1 exposure leads to
EMT and decreased Cldn1 in MDCKII cells (Medici et al., 2006). We suggest in the HM mouse
palate, the increased Cldn1 expression from 14.5 to 16.5dpc indicates a persistence of cell-cell
adhesion and therefore a persistence of the MEE and periderm ultimately hindering palate fusion.
Lysyl oxidase (Lox) is an enzyme essential for basement membrane development and
maturation. Active Lox modifies collagen formation to help stabilize a functional ECM; in excess,
Lox can lead to compromised basement mebrane function promoting abnormal ECM accumulation
and fibrotic diseases. Lox has also been shown to promote apoptosis and act as a tumor suppressor
(Kim et al., 2017). In lung cancer, TGF- is shown to increase LOX contributing to cancer
metastasis (Araz et al., 2014). In the HM palate, Lox may be upregulated as a result of Tgf-1 and
Tgf-2 maintaining ECM homeostasis necessary for palatal growth with no role in palate fusion
seen in WT mice.
Integrin 4 (Itgb4) is a member of the integrin family of cell adhesion receptors essential
for cell migration in embryonic development, wound healing, inflammatory responses, and tumor
metastasis. Expressed in epithelial cells, Itgb4 is a component of hemidesmosomes that provides
attachment to the basement membrane (Miyazaki et al., 2015). Tgf-1 is known to regulate
expression of several integrins. The addition of Tgf-1 to various cell types resulted in cytoskeletal
reorganization of the 4 integrin subunit (Scardigli et al., 1996) suggesting the upregulation of
Itgb4 in the HM palate is under control of Tgf-1; this upregulation is important for palatal growth
and elevation by modulating basement membrane with palatal epithelia. Further, Itgb4 seems to
have to no role in palate fusion which is strictly regulated by Tgf-3 in WT palates.
Transcription factor Klf5 belongs to the zinc-finger protein family and acts downstream of
multiple signaling pathways including TGF-. Klf5 is a known modulator of proliferation,
differentiation, cell cycle, and apoptosis and has been associated with different cancers and
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cardiovascular disease (Li et al., 2015). In HM palatal epithelia, Klf5 is independent of regulatory
Tgf-3, however it continues to be regulated by both Tgf-1 and Tgf-2 showing its increased
presence at 16.5dpc. Such upregulation of Klf5 gene in palatal epithelia in HM mice indicates
palatal epithelial growth, but no relationship with fusion.
5.3 Genes Downregulated at 16.5dpc vs. 14.5dpc in Homozygous Palates
As previously mentioned, Wnt family members are critical to orofacial development.
Further, Wnt signaling pathways regulate a variety of developmental processes, including cell
proliferation, differentiation and cell polarity that are fundamental in palate development (Cadigan
& Nusse, 1997, Wodarz & Nusse, 1998). Both Wnt3 and Wnt9b are expressed in the developing
facial ectoderm and the canonical Wnt signaling pathway is activated during facial outgrowth and
fusion (Lan et al., 2006). Thus, in mice, reduced Wnt9b expression or lack of Wnt signaling
pathways, as seen in HM embryos, contributes to failure in palatal morphogenesis resulting in
palatal cleft.
Alx4 is a paired-like homeodomain transcription factor that is mainly expressed in the
mesenchymal tissues of developing bone, teeth, limbs and mammary tissue. It plays a pivotal role
in craniofacial development and epithelial-mesenchymal interaction. Several studies have revealed
mutations of Alx4 cause craniofacial anomalies, including facial clefting (Beverdam et al., 2001).
During the development of the palate, as the palatal shelves adhere at the midline, two layers of
intervening MEE cells form the MES which must be subsequently dissolved to allow successful
palate fusion. EMT is thought to be an important mechanism required for MES disintegration
(Nawshad, 2008). Deletion of Alx4 was demonstrated to induce reversion of EMT (Yuan et al.,
2015, Hudson et al., 1998). Therefore, loss of Alx4 in HM palates may impair EMT during palatal
fusion and impede breakdown of MES resulting in a palatal cleft.
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Pax1 is a member of the paired box (PAX) family of transcription factors. Members of
PAX family play critical roles in pattern formation during embryogenesis and may be essential for
development of the vertebral column (Sonnesen et al., 2008). High DNA methylation rates of Pax1
are detected in tissues of several types of cancers, suggesting that Pax1 acts as a tumor suppressor
gene (Guerrero-Preston et al., 2014). Inactivation of Pax1 gene may result in enhanced resistance
to apoptosis and repression of terminal differentiation (Su et al., 2009, Kan et al., 2014, Cheng et
al., 2016, Hassan et al., 2017). In our RNA-seq data, downregulated expression of Pax1 in HM
palates may be responsible for persistence of periderm cells which bolsters the persistence of the
MES and ultimately leads to failure of fusion in palatal development.
Kcp is a secreted cysteine-rich domain protein and acts as a regulator of the TGF-β
superfamily pathways which enhances BMP signaling while inhibiting both the activin-A and TGF1-mediated signaling pathways (Soofi et al., 2017). BMP signaling is essential during organ
development, including palatogenesis. Specifically, BMP2, BMP4, and BMP5 are expressed in
both epithelia and mesenchyme throughout palatogenesis (Nie et al., 2006). Lu et al. showed the
importance of BMP signaling during palatogenesis by demonstrating a decrease expression of
Bmp2, -4, and -5 in mice exhibiting cleft palate (Lu et al., 2000). In our HM samples, deficiency of
Kcp may alter the levels of Bmp signaling, leading to aberrant cell proliferation and cell death
during palatal development, resulting in palatal cleft.
Msx1, like the Kcp gene, is also known to regulate BMP signaling; BMP signaling has been
proposed to be downstream of Msx1 during palatal development (Zhang et al., 2002). Msx1, a
member of the Muscle Segment Homeobox gene family, acts as a transcriptional repressor and
functions in diverse cell types regulating proliferation, differentiation and angiogenesis (Medio et
al., 2012). Msx1 is primarily expressed in the growing edges of maxillary prominences and the
anterior part of the palatal shelves as palatogenesis enters later stages (Hilliard et al., 2005, Zhang
et al., 2002).

Mice with null mutation of Msx1 develop cleft palate—clearly demonstrating a
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critical role of Msx1 in palate development (Satokata & Maas, 1994). As shown in our HM mice,
reduced expression of Msx1 at 16.5dpc is indicative of cleft palate.
Ppp1r17 is a substrate for cGMP-dependent protein kinase and is involved in central
nervous system development and intracellular signal transduction. Ppp1r17 implements protein
serine/threonine phosphatase inhibitor activity and inhibits phosphatase activities of protein
phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) complexes (Endo et al., 1999). During
embryonic development, cellular and molecular activities are regulated by phosphorylation and
dephosphorylation by protein kinases and phosphatases, respectively. Palatogenesis relies on a
multitude of orchestrated signal transduction pathways, such as TGF-, requiring protein
phosphorylation and enzymatic dephosphorylation. In embryonic murine palates, Pp1 and Pp2a
were reported to account for virtually all detectable serine/threonine protein phosphatase activity
during palatogenesis (Weston et al., 2002). Therefore, decreased expression of Pp1 or Pp2a due
to impaired function of Ppp1r17 may cause disruption in orchestration of Tgf- signaling pathways
and ultimately cell proliferation, epithelial differentiation, and apoptosis in palatal development of
HM mice. As demonstrated in the HM mouse at 16.5dpc, decreased Ppp1r17 and resulting
dysfunction of Tgf- pathways results in cleft palate.
Pdgfc is a member of the platelet-derived growth factor (PDGF) family and plays an
essential role in the regulation of multiple biological processes including embryonic development,
cell proliferation, cell migration and survival. The role of Pdgfc as a mitogenic factor in regulating
proliferation of mouse embryonic palatal mesenchymal cells has been well established (Ding et al.,
2004, Han et al., 2006). Pdgfc deficiency induces retardation of mesenchymal proliferation and
differentiation in palatal shelves, which accounts for failure of palate fusion and cleft formation in
Pdgfc (−/−) embryos (Ding et al., 2004). Although retardation of palatal growth in Tgf-3 knockout
mice is not observed, this does not exclude a disruption in palatal mesenchymal homeostasis due
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to the reduction of Pdgfc. As seen in the HM mouse at 16.5dpc, a decrease in Pdgfc could
potentially result in inadequate EMT—a fundamental process in successful palate fusion.
5.4 Genes Upregulated at 16.5dpc vs. 14.5dpc in Wild-type Palates
In WT palates, several genes under the control of Tgf-3 are significantly differentially
expressed compared to HM; consequent lack of these temporal gene changes in HM results in
palatal cleft. It is important to reiterate that all isoforms of TGF- ligand (1, 2 and 3) are crucial
for normal palate development. These isoforms act in tandem in a well-orchestrated time and
location dependent manner. Although mutants of these isoforms result in CP phenotype with
differing degrees of penetrance (Tgf-1 is embryonically lethal, 20% for Tgf-2); it is Tgf-3 that
causes 100% penetrance with CP as the only phenotype (Zhu et al., 2012b). However, the
compromise of cellular and morphological functions of these isoforms vary significantly. Our data
reveals that upregulated WT genes—Cdh1, Ocln, Lyn, F2rl1, Tspan2, and Tnfrsf11B—may
contribute to normal palate fusion.
The cell-cell adhesion protein E-cadherin (Cdh1) is a member of the cadherin family of
calcium-dependent cell adhesion glycoproteins (Becker et al., 1994). Just like all epithelia, the
palatal shelf epithelium expresses Cdh1 during palatogenesis. Mutation of the Cdh1 gene has been
shown to cause CL/P (Meng et al., 2009). In WT mice Cdh1 is upregulated from 14.5 to 16.5dpc.
At 14.5dpc Cdh1 is essential for integrity of MEE and overlying periderm of the palatal shelves.
As the palate fuses we expect dissolution of MEE and periderm with a localized decrease in
epithelial cells and therefore Cdh1 (Nawshad et al., 2007). However, at 16.5dpc we expect a
significant increase of stratified squamous epithelial cells lining the oral and nasal sides of the
palate resulting in an overall increase in Cdh1.
Similar to Cdh1, the transmembrane protein Occludin (Ocln) plays a role in tight junction
assembly of different epithelia, which is also upregulated at 16.5dpc in WT palate (Mir et al.,
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2016b). Ocln is essential for homeostasis of epithelia; any decrease in Ocln decreases cell-cell
adhesion and reduces apoptosis (Mir et al., 2016a). With the increase in quantity of epithelial cells
in WT palates, we also expect an increase in occludin. Both of these genes, Cdh1 and Ocln, enforce
palatal epithelial adhesion as well as maintain epithelial architectural and functional integrity—
hence their increase in WT is expected and justified.
The lyn gene belongs to the protein kinase superfamily and is localized to the cell surface
(Roberts et al., 2014). Lyn plays an important role in immune response, hematopoiesis, response
to growth factors and cytokines, and integrin signaling (Lim et al., 2015). Studies show that Tgf-
is involved in phosphorylation of Lyn and specifically have shown a link between Lyn and Tgf- in
chronic myeloid leukemia (CML) (Li et al., 2013). Using MYL cells from a CML patient, it was
found that TGF drives LYN ubiquitination and turnover via c-cbl transcription and expression
(Smith et al., 2012). Similarly, Tgf- control may be contributing to the increased presence of Lyn
in WT palates at 16.5dpc to facilitate integrin signaling as well as maintaining normal palatal
immune response and homeostasis.
F2R like trypsin receptor 1 (F2rl1), also known as Par2, is a member of the G-protein
coupled receptor family of proteins serving pleiotropic functions in vertebrate development and
postnatal homeostasis (Sales et al., 2015).

Par2 is expressed in various cell types including

gastrointestinal tract, skin, lung, kidneys, smooth muscle, endothelium, epithelium and fibroblasts.
Par2 has been found to induce colonic inflammation, kidney inflammation, and tissue fibrosis
(Chung et al., 2013). G-protein coupled receptors are known to transactivate EGFR in various cell
types. An in vitro study showed Par2 transactivates EGF and TGF--receptors via PI3K and
MAPKs ultimately leading to phosphorylation of Smad2 and -3. Smad2/3 phosphorylation is
essential to TGF--dependent signaling and activation of transcription factors to facilitate palatal
cell proliferation, differentiation, and apoptosis (Chung et al., 2013).

Additional signaling
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pathways and proteins, such as G-protein coupled receptors, play a critical role in palate
development as demonstrated by its increase in WT palates at 16.5dpc (Cobourne, 2004).
Tetraspanins (Tspans) consist of a large family of 4-transmembrane domain proteins.
Tspans have recently gained importance as regulators in cancer malignancy, immune response,
fertilization, and infectious disease (Zhao et al., 2017). Tspans have been shown to play crucial
roles in biologic processes including cell adhesion, proliferation, differentiation, and migration
(Zhao et al., 2017) . Recently Tspan2 has been found to be the only Tspan family gene induced by
TGF- in vascular smooth muscle cells via class SMAD pathway (Zhao, Wu et al. 2017). While
there is no direct link of Tspan2 to palatogenesis, its implication with TGF-/SMAD pathway and
crucial role in cell adhesion, proliferation, and differentiation warrant further investigation into its
role in palatogenesis. However, our data suggest that the role of Tspan2 may be limited to cellular
migration, proliferation and different ion via Smad pathways during palatogenesis.
Osteoprotegrin (Tnfrs11b) is a key regulator of bone metabolism and is crucial for bone
homeostasis; Tnfrs11b inhibits osteoclast activity allowing new bone formation by osteoblasts
(Smane & Pilmane, 2016). Tnfrs11b knockout mice have severe osteoporosis while overexpression
leads to osteopetrosis (Zehnder et al., 2006). As early as 14.5dpc, mesenchymal condensations are
observed on both sides of the palatal midline which undergo chondrogenesis initially and ultimately
membranous ossification that give rise to the hard palate (Martinez-Alvarez et al., 2004). We
expect Tnfrs11b signaling to be upregulated from 14.5 to 16.5dpc in preparation for osteogenesis.
5.5 Genes Downregulated at 16.5dpc vs. 14.5dpc in Wild-type Palates
As previously described, downregulation of WT genes allow normal palate fusion. Our
data show decreased expression of Fndc3c1, Dlx1, Gas2, Bnc2 and Vcan facilitate successful palate
fusion.
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Fndc3c1, a member of a novel gene family, encodes a protein consisting of fibronectin
module type III and is a component of ECM proteins functioning in cell adhesion, differentiation,
migration and embryogenesis (Porcionatto, 2006, Potts & Campbell, 1996). Although Fndc3c1 is
mostly expressed in all embryonic germ layers except heart and yolk sac from E7.5-E8.5 (Hou et
al., 2007).

Further, Fndc3c1 is shown to be expressed in trophoblast stem cells during

extraembryonic ectoderm differentiation in mice (Pearton et al., 2014). During palate formation,
ectoderm-derived MEE and periderm are created to form a protective shield against premature
fusion, but must dislodge prior to shelf adherence to allow a confluent palate (Obholz et al., 2006,
Nawshad, 2008, Hu et al., 2015b). Therefore, it’s logical to postulate that reduced expression of an
ectoderm differentiation gene, Fndc3c1, may facilitate elimination of periderm from underlying
epithelium allowing palate fusion.
Distal-Less Homeobox 1 (Dlx1) encodes a protein that functions as a transcriptional
regulator of signaling from several TGF- superfamily members. All six Dlx family members are
present in the first pharyngeal arch in both mesenchyme and ectoderm (Jeong et al., 2012). Mice
with mutations of both Dlx1 and Dlx2 exhibit cleft palate demonstrating the essential role of Dlx
family in palatogenesis (Jeong et al., 2012). At early stages in palate formation, the defect in Dlx
family genes results in a growth defect of palatal shelves. Later stages of palatogenesis are also
affected via Dlx1 and Dlx2 regulation of downstream signaling molecules such as Shh, Fgf10, and
Bmp4 (Jeong et al., 2012). Our RNA-seq data show decreased activity of Dlx1 at 16.5dpc in the
WT palates. We postulate that the decrease in Dlx1 prior to palatal fusion may allow Tgf-
signaling to properly guide dislodgment of periderm and subsequent fusion in palatogenesis.
Growth arrest specific gene 2 (Gas2) is a caspase-3 substrate that regulates cell cycle and
apoptosis (Sgorbissa, Benetti et al. 1999). The cleaved form of Gas2 is capable of modifying
microfilament and cell shape during apoptosis (Brancolini et al., 1995). Cell death by apoptosis is
a fundamental process maintaining normal development and homeostasis of multicellular
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organisms. During palatogenesis, MEE cells in the MES are proposed to, in part, undergo apoptosis
to facilitate mesenchymal confluence (Nawshad, 2008). In vitro, however, cultured murine
keratinocyte cells displayed reduced Gas2 protein levels during growth arrest induced by TGF-
treatment, whereas significantly upregulated Gas2 activity was observed in rapidly proliferating
cells (Manzow et al., 1996). Therefore, it is plausible to suggest that during palate fusion, lower
levels of Gas2 is a reflection of quiescent epithelial cells undergoing apoptosis or EMT instead of
robust proliferation. Future studies are necessary to investigate the role of Tgf- in regulating
expression of Gas2.
The Bnc2 gene encodes a conserved zinc finger protein containing three pairs of zinc
fingers and a nuclear localization signal (Vanhoutteghem et al., 2009). According to reports, Bnc2
plays a role in skin color saturation and skin cancer development (Jacobs et al., 2015). Bnc2 is
found mainly in keratinocytes of stratified squamous epithelium and is functionally involved in cell
proliferation (Vanhoutteghem et al., 2009). Observations of growth arrest of tumor cells induced
by stable expression of Bnc2 also supports Bnc2 as a putative tumor suppressor gene (Akagi et al.,
2009). In a recent study, Bnc2 was shown in mesenchymal cells surrounding the palatal cleft in
mice; while the exact role of Bnc2 is unclear, it likely regulates expression of genes that encode
transcription factors, genes essential for growth, and signaling molecules and receptors necessary
for successful palate fusion (Vanhoutteghem et al., 2009).

The involvement of Bnc2 in

palatogenesis warrants further investigation.
Versican (Vcan) is a chondroitin sulfate proteoglycan and component of the extracellular
matrix essential to embryogenesis; lack of Vcan is lethal in mice (Snyder et al., 2015). Vcan plays
a crucial role in various cellular processes including cell adhesion, proliferation, differentiation and
apoptosis; one isoform, V1, specifically promotes EMT (Snyder et al., 2015). Further, increasing
evidence has demonstrated that V1 is capable of inducing apoptotic resistance in cultured cells
(Sheng et al., 2005, LaPierre et al., 2007). Tgf-3-mediated apoptosis and subsequent disintegration
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of the MES is a critical event for successful palate fusion (Iordanskaia & Nawshad, 2011, Nawshad
et al., 2004, Kaartinen et al., 1997). Thus, it’s plausible that suppressed expression of Vcan at
16.5dpc allows the breakdown of the MES. While we know it is a critical gene, further examination
of Vcan activity throughout embryogenesis would be of benefit to our understanding as to how it
contributes to palatogenesis.
5.6 Dysregulated Genes independent of TGF-
The heat shock protein Crystallin-B (Cryab) is a member of the heat shock protein family
with an array of biological functions (Malin et al., 2016). Cryab is known to bind and stabilize
cytoskeletal proteins and play a role in EMT in liver and lung fibrosis (Malin et al., 2016). An in
vitro experiment in retinal pigment epithelial cells showed overexpression of Cryab siRNA
decreased E-cadherin and increased Snail and Slug in protein and mRNA levels (Ishikawa et al.,
2016). Snail family members have been implicated in triggering of EMT and cell survival (KudoSaito et al., 2009). Cryab, in relation to Snail, could be acting as an anti-apoptotic agent in
persistent palatal shelf epithelium and periderm. In cleft mice, increased levels of Tgf-1 in the
palatal mesenchyme induces Snail expression and inhibition of cell death in the MEE (MartinezAlvarez et al., 2004). Upregulated in HM mice at 16.5dpc, the relationship between Cryab and
Snail may be related to apoptosis of palatal mesenchyme and epithelia that are necessary in
palatogenesis requiring further investigation.
Neuronal cell adhesion molecule (Nr-cam) is a member of the immunoglobulin
superfamily and was recently identified as a target of gene signaling in human melanoma and colon
carcinoma cells and tissue (Conacci-Sorrell et al., 2005). Nr-cam protects cells from apoptosis via
extracellular signal-regulated kinase and AKT signaling pathways (Conacci-Sorrell et al., 2005).
The PI3K/Akt pathway suppresses apoptosis and promotes cell growth and proliferation (Bian et
al., 2009). Nr-Cam is upregulated in the HM palate at 16.5dpc and may be contributing to
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decreased apoptosis in persistent MEE and periderm of palatal shelves ultimately hindering palatal
fusion.
5.7 Direct Comparison of Homozygous and Wild-type Palates at 14.5 and 16.5dpc
The RNA sequencing data shows few differentially expressed genes when directly
comparing genotypes at 14.5 and 16.5dpc shown in Table 4.

At 14.5, only 13 genes were

differentially expressed between WT and HM ranging from FC -1.46 to 1.39—a very concentrated
difference between genotype in comparison to the differential gene expression over time.
Ephrins are a family of cell surface receptors involved in embryonic development
including the palate (Risley et al., 2009b). Ephrins are shown to be necessary for both cell
proliferation and palatal adhesion; further, multiple ephrin/eph receptors are responsible for normal
palate development (Risley et al., 2009a).

Mutations in the EphrinB1 gene are seen in

craniofrontonasal syndrome giving rise to cranial defects including cleft lip and palate in both
humans and mice (Risley et al., 2009b). Similarly, EphB2 and EphB3 have been implicated in
palate development and present in palatal mesenchyme and epithelium (Risley et al., 2009a).
Knockout of both EphB2 and EphB3 causes cleft palate in mice (Orioli et al., 1996). Differentially
expressed Ephb3 signaling directly affects palatogenesis, but the exact role of Ephb3 remains
undetermined.
Transcription factor Sox6 belongs to the Sox family and is expressed in various tissues; it
serves many regulatory functions in the development of mesoderm, ectoderm and endodermal
tissues. In the mouse model, Sox6 is expressed in the central nervous system, otic vesicle, somites
branchial arches, thymus notochord, craniofacial mesenchyme, limb buds, and liver (Hagiwara,
2011). Sox6 is implicated in both activation and suppression of gene transcription affecting genes
essential to palate development and known to contribute to cleft formation such as Fgf3 and Col2a1
(Küchler et al., 2014, Meng et al., 2009) . Sox6 negatively regulates expression of Fgf3 and
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activates Col2a1 (Hagiwara, 2011). Our current knowledge indicates Sox6 plays various roles in
embryonic development, warranting further investigation of its involvement in palatogenesis.
Keratin family proteins comprise the intermediate filament system in epithelial cells having
significant interactions with the ECM throughout key processes such as development, tissue
remodeling and repair, and differentiation (Kurpakus et al., 1992).

In the oral cavity,

immunostaining shows keratin in the oral periderm covering the maxillary processes, palatal
shelves, and future nasal cavity (Casey et al., 2006). Periderm has been previously characterized
by keratin expression (Paul et al., 2017, Iwasaki et al., 2006).

The oral periderm prevents the

palatal shelves from abhorrently adhering to other oral structures during palatogenesis; further,
periderm cell death is critical to facilitate palatal shelf adhesion (Casey et al., 2006). The genotypic
difference in Krt5 expression, upregulated in HM at 14.5dpc, is likely due to persistent periderm
and therefore increased expression in the palatal shelf epithelium.
Greater differences exist between genotypes at 16.5dpc; a total of 38 differentially
expressed genes existed between WT and HM at 16.5dpc ranging from FC -2.75 to 16.75 as shown
in Table 5.7. Epidermal growth factor receptor (Egfr) signaling is essential for normal craniofacial
development.

Egfr regulates development via downstream targets including matrix

metalloproteinases (Mmp) (Miettinen et al., 1999). Studies have shown abnormal function of Egfr
results in cleft palate (Meng et al., 2009). In Egfr deficient mice, it is postulated that palate adhesion
fails due to decreased Mmp presence (Miettinen et al., 1999).

Both Egfr and Mmp13 are

dysregulated between WT and HM at 16.5dpc; Egfr is upregulated in HM at 16.5dpc while Mmp13
is downregulated in HM at 16.5dpc.

The difference in expression between HM and WT

demonstrates the involvement of both Egfr signaling and its target Mmp13 in palatogenesis.
As previously mentioned, the collagen fibers are known to contribute to palatal shelf
elevation, shelf adhesion and ECM formation (Vandenberg et al., 1991). Increased presence of
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Col6a6 in HM compared to WT at 16.5dpc is indicative of increased presence of basement
membranes of persistent, intact palatal epithelia with periderm with a cleft.
Similar to its counterpart differentially expressed at 14.5, Krt4 is upregulated in HM at
16.5dpc. As previously discussed, the increased expression of Krt4 is indicative of persistent
periderm which will hinder proper palatal fusion in HM.
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14.5
Genotype
Comparison
16.5

# of
SDEG

Selected Genes

Up in HM 14.5 vs. WT 14.5

8

Ephb3, Krt5

Down in HM 14.5 vs. WT
14.5

5

Sox6

Up in HM 16.5 vs. WT 16.5

30

Egfr, Col6a6, Krt4

Down in HM 16.5 vs. WT
16.5

8

Mmp3

Table 4: Selected genes that are uniquely significantly differentially expressed within genotypes
at different time points (adjusted p-value < 0.05) in the HM or WT groups.
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5.8 Significantly Dysregulated Gene Ontology Categories & KEGG Pathways
Significantly differentially expressed genes were found both inter- and intra- time point
and genotype.

In order to identify predominant biological processes that are significantly

dysregulated, genes are grouped by common properties into GO categories, such as cell adhesion
(Young et al., 2010). Another method of categorizing genes is by KEGG functional assignment.
KEGG provides a link from a specific gene to pathway or complex, such as metabolism (Kanehisa
& Goto, 2000b).
Identified functional categories that are uniquely or commonly overrepresented in our
samples are listed in Figure 4.3c. In the HM palates, we see significantly upregulated functional
categories including ECM-receptor interaction, cell adhesion, and focal adhesion. We expect the
genes in these categories are likely contributing to the persistence of the periderm layer that
essentially impedes palate fusion (Nawshad et al., 2004). Conversely, in WT palates, celldifferentiation and apoptotic process are significantly overrepresented. As we expect, proper palate
fusion requires both cell-differentiation and apoptosis to remove the MES and allow proper fusion
(Nawshad et al., 2007).
5.9 Functional Analysis of SDEGs in WT and HM at 16.5 vs. 14.5dpc
The RNA-seq data shows that in WT at 16.5dpc of palatal development, several pathways
are active and functional including: TGF-, ERK/MAPK, p38 MAPK, and PI3K/AKT. It is known
that these pathways are under the control of TGF-; however, they can also be regulated by other
factors active in palate development at 16.5dpc. These pathways are shown to regulate genes
displayed in Figure 5.1. The p38 MAPK pathway is a key mediator downstream of TGF- pathway
which synergistically causes downregulation of the transcriptional regulator Gsc as demonstrated
in Figure 5.2. Gsc is reported to regulate cell migration and EMT during embryonic development
suggesting inhibition of Gsc indicates completion of palate fusion at 16.5dpc (Xue et al., 2014).
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Tgf-1 conjointly with p38 MAPK and additional molecules shown in Figure 5.3 regulate cell
morphology and differentiation of fibroblasts that lend to construction of ECM and EMT during
palate development (Griffith & Hay, 1992, Kalluri & Weinberg, 2009).
Conversely in HM, the major pathways illustrate a different regulatory profile at 16.5dpc
which results in cleft palate as shown in Figure 5.4. As in the Tgf-3 knockout, Tgf-3 signaling
is inactive allowing PI3K/AKT and ERK/MAPK pathways to impair normal palate fusion by
altering the expression of Tlx2 as shown in Figure 5.5. The Tlx2 gene plays a role in proliferation
and differentiation of neural crest cell lines (Nelms & Labosky, 2010). Although the involvement
of Tlx2 in palatogenesis is largely unexplored, Tlx2 has been reported in diseases associated with
cleft palate (Puri & Shinkai, 2004). Genes illustrated in Figure 5.6, such as Tbx3 and Wnt9b, that
participate in regulating crucial biological processes including cell morphology and embryonic
morphogenesis show altered expression levels at 16.5dpc in HM and may be responsible for failure
of palate fusion.
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Figure 12. Upregulated or downregulated significantly differentially expressed genes (SDEG), fold
change >2.0, and relevant pathways over time 14.5dpc to 16.5dpc in WT palates
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Figure 13. Illustration of SDEGs in TGF-3 signaling pathway related to major pathways expressed in WT.
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Figure 14. SDEGs from 14.5dpc to 16.5dpc in relation to cell morphology and
differentiation of fibroblasts in WT.
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Figure 15. Upregulated or downregulated SDEGs, fold change >2.0, and relevant
pathways over time 14.5dpc to 16.5dpc in HM palates
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Figure 16. Illustration of SDEGs in TGF-3 signaling pathway in relation to major pathways in HM.
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Figure 17. SDEGs from 14.5dpc to 16.5dpc in relation to morphology of
cells and morphogenesis of embryo in HM.
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5.10 Real-time PCR confirmation of Gene Dysregulation
Our qPCR data is in agreement with our RNA-seq results, shown in Figure 4.4,
demonstrating at 16.5dpc WT palates have an increased expression of the cell adhesion genes Cdh1,
Ocln and receptors F2rl1 (Par2) which are essential in palatal MEE cell architecture and play a
vital role in palatal shelf fusion allowing palatal confluency. On the contrary, we observe a
downregulation of Tnfrsf11b, important for osteoclastogenesis, hence, its requirement in palate
development is negligible (Naranjo et al., 2016). Similarly, Fndc3c1 is mostly expressed in
embryonic endoderm, serving little role in palatal embryonic cell origin which are ectoderm and
ectomesenchymes (Hou et al., 2007). Although Dlx1 gene is important for craniofacial and palatal
vertical out growth, its role in palatal fusion as shown in our study has not been reported (Wu et
al., 2015, Jeong et al., 2012). Similarly, Gas2, which has been implicated in skeletal development,
has no implication in embryonic palate development (Diez-Roux et al., 2011). Accordingly, all
genes unessential to palate fusion (Tnfrsf11b, Fndc3c1, Dlx1 and Gas2) were shown to be
downregulated in our study.
In HM, qPCR data shown in Figure 4.41 confirms RNA-seq results showing an increased
expression of Chrng, Col2a1, Coll11a1, Col11a2, L1cam, Adam12, Fas, Hspg2, Lox, Itgb4, Klf5,
Cldn1 and Nr-cam. First, several genes upregulated in HM palates have been confirmed as known
CP genes including: Chrng, Col2a1, Col11a1, Col11a2, and L1cam (Vogt et al., 2012, Meng et al.,
2009, Schutte & Murray, 1999, Okamoto et al., 2004, Dixon et al., 2011). Second, in the Tgf-3
knockout mouse model, we expect other isoforms, Tgf-1 and Tgf-2 to maintain activity and
continue control of Adam12, Fas, Hspg2, Lox, Itgb4, Klf5, and Cldn1 as previously discussed
(Ramdas et al., 2013, Matsushima & Ishiyama, 2016, Ichimaru et al., 2012, Araz et al., 2014,
Scardigli et al., 1996, Li et al., 2015, Medici et al., 2006). Finally, independent of Tgf- control,
Nr-cam uses AKT signaling pathway to protect cells from apoptosis—an essential component of
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normal palate fusion (Nawshad, 2008, Conacci-Sorrell et al., 2005). We postulate this decreased
apoptosis lends to cleft formation.
Genes downregulated at 16.5dpc in HM palates—Wnt9b, Alx4, Pax1, Kcp, Msx1, Ppp1r17,
Pdgfc, Twist1, and Wnt5a—are also in agreement with RNA-seq results. Downregulation of genes
essential for embryogenesis, craniofacial development, and orofacial patterning (Wnt9b, Alx4,
Pax1, Kcp, Msx1, Ppp1r17, and Pdgfc) likely disrupts fundamental processes required for normal
palate fusion as previously discussed (Cadigan & Nusse, 1997, Beverdam et al., 2001, Sonnesen et
al., 2008, Soofi et al., 2017, Zhang et al., 2002, Weston et al., 2002, Ding et al., 2004).
Additionally, we confirm downregulation of known CP genes, Twist1 and Wnt5a, in HM palates
(Dixon et al., 2011, Meng et al., 2009).
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CHAPTER 6: CONCLUSION
6.1 Conclusion
Our study is the first global gene analysis of Tgf- knockout mice alleles using deep
sequencing methods. While we know Tgf-3 is essential for proper palate fusion, we do not know
what downstream molecular mechanisms are altered in Tgf-3 knockouts. In this study, we
identified a multitude of significantly differentially expressed genes both temporally and between
phenotypes that may play key regulatory roles during critical stages of palate development. The
genes implicated in CP may lead to a better understanding of the underlying genetic mechanisms
of palatogenesis and provide novel potential targets for gene therapy approaches in treating cleft
palate.
6.2 Future Research and Study Limitations
Global transcriptome profiling provides a multitude of genetic information. We have
provided various genes that warrant further investigation on their involvement in palatogenesis.
Continued exploration of genes dysregulated in Tgf- alleles will further contribute to our
knowledge of downstream molecular activities and pathways controlled by Tgf-, ultimately
enhancing our understanding of CP deformity and providing new genetic targets for prevention and
treatment.
First, limitations of this study include several difficulties with a murine model. Research
animals are expensive and do not predictively reproduce. This specific strain also experienced a
virus during the time of the study in which all breeding was halted. Further, the tissues from mouse
embryo palates are very small, difficult to extract, and provide very few cells. Second, this study
evaluates an animal model; therefore, we cannot assume the effect of TGF- is identical in humans.

68
BIBLIOGRAPHY
Ahmad NN, Dimascio J, Knowlton RG and Tasman WS (1995). Stickler syndrome. A mutation in the
nonhelical 3' end of type II procollagen gene. Arch Ophthalmol 113: 1454-7.
Akagi T, Ito T, Kato M, Jin Z, Cheng Y, Kan T, Yamamoto G, Olaru A, Kawamata N and Boult J (2009).
Chromosomal abnormalities and novel disease‐related regions in progression from Barrett's
esophagus to esophageal adenocarcinoma. International journal of cancer 125: 2349-2359.
Alappat S, Zhang ZY and Chen YP (2003). Msx homeobox gene family and craniofacial development.
Cell Res 13: 429-42.
Andrews S (2010). FastQC: A quality control tool for high throughput sequence data. Reference Source:
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
Araz O, Demirci E, Yilmazel Ucar E, Calik M, Karaman A, Durur‐Subasi I, Orsal E, Subasi M, Daloglu F
and Akgun M (2014). Roles of Ki‐67, p53, transforming growth factor‐β and lysyl oxidase in the
metastasis of lung cancer. Respirology 19: 1034-1039.
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS,
Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE,
Ringwald M, Rubin GM and Sherlock G (2000). Gene ontology: tool for the unification of
biology. The Gene Ontology Consortium. Nat Genet 25: 25-9.
Beaty TH, Hetmanski JB, Fallin MD, Park JW, Sull JW, McIntosh I, Liang KY, Vanderkolk CA, Redett
RJ, Boyadjiev SA, Jabs EW, Chong SS, Cheah FS, Wu-Chou YH, Chen PK, Chiu YF, Yeow V,
Ng IS, Cheng J, Huang S, Ye X, Wang H, Ingersoll R and Scott AF (2006). Analysis of candidate
genes on chromosome 2 in oral cleft case-parent trios from three populations. Hum Genet 120:
501-18.
Becker K-F, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR and Höfler H (1994). E-cadherin
gene mutations provide clues to diffuse type gastric carcinomas. Cancer research 54: 3845-3852.

69
Benjamini Y and Hochberg Y (1995). Controlling the false discovery rate: A practical and powerful
approach to multiple testing. J. Roy. Statist. Soc. Ser. B. 57: 289-300.
Beverdam A, Brouwer A, Reijnen M, Korving J and Meijlink F (2001). Severe nasal clefting and
abnormal embryonic apoptosis in Alx3/Alx4 double mutant mice. Development 128: 3975-3986.
Bian Y, Terse A, Du J, Hall B, Molinolo A, Zhang P, Chen W, Flanders KC, Gutkind JS, Wakefield LM
and Kulkarni AB (2009). Progressive tumor formation in mice with conditional deletion of TGFbeta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.
Cancer Res 69: 5918-26.
Bolger AM, Lohse M and Usadel B (2014). Trimmomatic: a flexible trimmer for Illumina sequence data.
Bioinformatics 30: 2114-20.
Brancolini C, Benedetti M and Schneider C (1995). Microfilament reorganization during apoptosis: the
role of Gas2, a possible substrate for ICE-like proteases. The EMBO journal 14: 5179.
Brugmann SA, Goodnough LH, Gregorieff A, Leucht P, Ten Berge D, Fuerer C, Clevers H, Nusse R and
Helms JA (2007). Wnt signaling mediates regional specification in the vertebrate face.
Development 134: 3283-95.
Cadigan KM and Nusse R (1997). Wnt signaling: a common theme in animal development. Genes &
development 11: 3286-3305.
Casey LM, Lan Y, Cho ES, Maltby KM, Gridley T and Jiang R (2006). Jag2‐Notch1 signaling regulates
oral epithelial differentiation and palate development. Developmental dynamics 235: 1830-1844.
Chai Y and Maxson RE, Jr. (2006). Recent advances in craniofacial morphogenesis. Dev Dyn 235: 235375.
Cheng S-J, Chang C-F, Lee J-J, Chen H-M, Wang H-J, Liou Y-l, Yen C and Chiang C-P (2016).
Hypermethylated ZNF582 and PAX1 are effective biomarkers for detection of oral dysplasia and
oral cancer. Oral oncology 62: 34-43.

70
Chiquet BT, Blanton SH, Burt A, Ma D, Stal S, Mulliken JB and Hecht JT (2008). Variation in WNT
genes is associated with non-syndromic cleft lip with or without cleft palate. Hum Mol Genet 17:
2212-8.
Chung H, Ramachandran R, Hollenberg MD and Muruve DA (2013). Proteinase-activated receptor-2
transactivation of epidermal growth factor receptor and transforming growth factor-β receptor
signaling pathways contributes to renal fibrosis. Journal of Biological Chemistry 288: 3731937331.
Cobourne MT (2004). The complex genetics of cleft lip and palate. European Journal of Orthodontics 26:
7-16.
Conacci-Sorrell M, Kaplan A, Raveh S, Gavert N, Sakurai T and Ben-Ze'ev A (2005). The shed
ectodomain of Nr-CAM stimulates cell proliferation and motility, and confers cell transformation.
Cancer research 65: 11605-11612.
Cordero DR, Brugmann S, Chu Y, Bajpai R, Jame M and Helms JA (2011). Cranial neural crest cells on
the move: their roles in craniofacial development. Am J Med Genet A 155A: 270-9.
Cui XM, Chai Y, Chen J, Yamamoto T, Ito Y, Bringas P and Shuler CF (2003). TGF‐β3–dependent
SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion.
Developmental dynamics 227: 387-394.
Diez-Roux G, Banfi S, Sultan M, Geffers L, Anand S, Rozado D, Magen A, Canidio E, Pagani M and
Peluso I (2011). A high-resolution anatomical atlas of the transcriptome in the mouse embryo.
PLoS biology 9: e1000582.
Ding H, Wu X, Bostrom H, Kim I, Wong N, Tsoi B, O'Rourke M, Koh GY, Soriano P, Betsholtz C, Hart
TC, Marazita ML, Field LL, Tam PP and Nagy A (2004). A specific requirement for PDGF-C in
palate formation and PDGFR-alpha signaling. Nat Genet 36: 1111-6.
Dixon MJ, Marazita ML, Beaty TH and Murray JC (2011). Cleft lip and palate: understanding genetic
and environmental influences. Nat Rev Genet 12: 167-78.

71
Endo S, Suzuki M, Sumi M, Nairn AC, Morita R, Yamakawa K, Greengard P and Ito M (1999).
Molecular identification of human G-substrate, a possible downstream component of the cGMPdependent protein kinase cascade in cerebellar Purkinje cells. Proceedings of the National
Academy of Sciences 96: 2467-2472.
Goldthorpe H, Jiang J-Y, Taha M, Deng Y, Sinclair T, Ge CX, Jurasz P, Turksen K, Mei SH and Stewart
DJ (2015). Occlusive lung arterial lesions in endothelial-targeted, fas-induced apoptosis
transgenic mice. American journal of respiratory cell and molecular biology 53: 712-718.
Griffith CM and Hay ED (1992). Epithelial-mesenchymal transformation during palatal fusion:
carboxyfluorescein traces cells at light and electron microscopic levels. Development 116: 108799.
Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN,
Yegnasubramanian S, Hadar T, Noordhuis MG and Zizkova V (2014). Key tumor suppressor
genes inactivated by “greater promoter” methylation and somatic mutations in head and neck
cancer. Epigenetics : official journal of the DNA Methylation Society 9: 1031-1046.
Hagiwara N (2011). Sox6, jack of all trades: a versatile regulatory protein in vertebrate development.
Developmental Dynamics 240: 1311-1321.
Han J, Xiao Y, Lin J and Li Y (2006). PDGF‐C Controls proliferation and is down‐regulated by retinoic
acid in mouse embryonic palatal mesenchymal cells. Birth Defects Research Part B:
Developmental and Reproductive Toxicology 77: 438-444.
Hara T, Yoshida E, Fujiwara Y, Yamamoto C and Kaji T (2017). Transforming Growth Factor‐β1
Modulates the Expression of Syndecan‐4 in Cultured Vascular Endothelial Cells in a Biphasic
Manner. Journal of cellular biochemistry 118: 2009-2017.
Hassan ZK, Hafez MM, Kamel MM and Zekri ARN (2017). Human Papillomavirus Genotypes and
Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer
Patients. Asian Pacific journal of cancer prevention: APJCP 18: 169.

72
He F, Xiong W, Yu X, Espinoza-Lewis R, Liu C, Gu S, Nishita M, Suzuki K, Yamada G, Minami Y and
Chen Y (2008). Wnt5a regulates directional cell migration and cell proliferation via Ror2mediated noncanonical pathway in mammalian palate development. Development 135: 3871-9.
Hilliard SA, Yu L, Gu S, Zhang Z and Chen YP (2005). Regional regulation of palatal growth and
patterning along the anterior-posterior axis in mice. J Anat 207: 655-67.
Hoffmann K, Müller JS, Stricker S, Megarbane A, Rajab A, Lindner TH, Cohen M, Chouery E, Adaimy
L and Ghanem I (2006). Escobar syndrome is a prenatal myasthenia caused by disruption of the
acetylcholine receptor fetal γ subunit. The American Journal of Human Genetics 79: 303-312.
Hou J, Charters AM, Lee SC, Zhao Y, Wu MK, Jones SJ, Marra MA and Hoodless PA (2007). A
systematic screen for genes expressed in definitive endoderm by Serial Analysis of Gene
Expression (SAGE). BMC developmental biology 7: 92.
Hu L, Liu J, Li Z, Ozturk F, Gurumurthy C, Romano RA, Sinha S and Nawshad A (2015a). TGFbeta3
regulates periderm removal through DeltaNp63 in the developing palate. J Cell Physiol 230:
1212-25.
Hu L, Liu J, Li Z, Ozturk F, Gurumurthy C, Romano RA, Sinha S and Nawshad A (2015b). TGFβ3
regulates periderm removal through ΔNp63 in the developing palate. Journal of cellular
physiology 230: 1212-1225.
Huang da W, Sherman BT and Lempicki RA (2009). Systematic and integrative analysis of large gene
lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
Hudson R, Taniguchi-Sidle A, Boras K, Wiggan ON and Hamel PA (1998). Alx-4, a transcriptional
activator whose expression is restricted to sites of epithelial-mesenchymal interactions.
Developmental dynamics 213: 159-169.
Ichikawa E, Watanabe A, Nakano Y, Akita S, Hirano A, Kinoshita A, Kondo S, Kishino T, Uchiyama T,
Niikawa N and Yoshiura K (2006). PAX9 and TGFB3 are linked to susceptibility to
nonsyndromic cleft lip with or without cleft palate in the Japanese: population-based and familybased candidate gene analyses. J Hum Genet 51: 38-46.

73
Ichimaru Y, Krimmer DI, Burgess JK, Black JL and Oliver BG (2012). TGF-β enhances deposition of
perlecan from COPD airway smooth muscle. American Journal of Physiology-Lung Cellular and
Molecular Physiology 302: L325-L333.
Iordanskaia T and Nawshad A (2011). Mechanisms of transforming growth factor beta induced cell cycle
arrest in palate development. J Cell Physiol 226: 1415-24.
Ishikawa K, Sreekumar PG, Spee C, Nazari H, Zhu D, Kannan R and Hinton DR (2016). αB-Crystallin
Regulates Subretinal Fibrosis by Modulation of Epithelial-Mesenchymal Transition. The
American journal of pathology 186: 859-873.
Itahana Y, Piens M, Sumida T, Fong S, Muschler J and Desprez P-Y (2007). Regulation of clusterin
expression in mammary epithelial cells. Experimental cell research 313: 943-951.
Iwasaki S-i, Aoyagi H and Asami T (2006). Expression of keratin 18 in the periderm cells of the lingual
epithelium of fetal rats: visualization by fluorescence immunohistochemistry and differential
interference contrast microscopy. Odontology 94: 64-68.
Iwata J, Parada C and Chai Y (2011). The mechanism of TGF-beta signaling during palate development.
Oral Dis 17: 733-44.
Jacobs LC, Hamer MA, Gunn DA, Deelen J, Lall JS, Van Heemst D, Uh H-W, Hofman A, Uitterlinden
AG and Griffiths CE (2015). A genome-wide association study identifies the skin color genes
IRF4, MC1R, ASIP, and BNC2 influencing facial pigmented spots. Journal of Investigative
Dermatology 135: 1735-1742.
Jeong J, Cesario J, Zhao Y, Burns L, Westphal H and Rubenstein JL (2012). Cleft palate defect of
Dlx1/2−/− mutant mice is caused by lack of vertical outgrowth in the posterior palate.
Developmental Dynamics 241: 1757-1769.
Jugessur A, Farlie P and Kilpatrick N (2009). The genetics of isolated orofacial clefts: from genotypes to
subphenotypes. Oral diseases 15: 437-453.

74
Kaartinen V, Cui XM, Heisterkamp N, Groffen J and Shuler CF (1997). Transforming growth factorbeta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated
degradation of the basement membrane. Dev Dyn 209: 255-60.
Kalluri R and Weinberg RA (2009). The basics of epithelial-mesenchymal transition. The Journal of
clinical investigation 119: 1420.
Kan Y-Y, Liou Y-L, Wang H-J, Chen C-Y, Sung L-C, Chang C-F and Liao C-I (2014). PAX1
methylation as a potential biomarker for cervical cancer screening. International Journal of
Gynecological Cancer 24: 928-934.
Kanehisa M and Goto S (2000a). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res
28: 27-30.
Kanehisa M and Goto S (2000b). KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids
research 28: 27-30.
Kariminejad A, Almadani N, Khoshaeen A, Olsson B, Moslemi A-R and Tajsharghi H (2016). Truncating
CHRNG mutations associated with interfamilial variability of the severity of the Escobar variant
of multiple pterygium syndrome. BMC genetics 17: 71.
Katayama A, Handa T, Komatsu K, Togo M, Horiguchi J, Nishiyama M and Oyama T (2017).
Expression patterns of claudins in patients with triple‐negative breast cancer are associated with
nodal metastasis and worse outcome. Pathology International.
Kim D, Mecham RP, Trackman PC and Roy S (2017). Downregulation of Lysyl Oxidase Protects Retinal
Endothelial Cells From High Glucose–Induced ApoptosisLOX and Apoptosis in Retinal
Endothelial Cells. Investigative Ophthalmology & Visual Science 58: 2725-2731.
Küchler EC, Sabóia TM, Vieira TC, Lips A, Tannure PN, Deeley K, Reis MF, Ho B, Rey AC and Costa
MC (2014). Studies of genes involved in craniofacial development and tumorigenesis: FGF3
contributes to isolated oral clefts and may interact with PAX9. Acta Odontologica Scandinavica
72: 1070-1078.

75
Kudo-Saito C, Shirako H, Takeuchi T and Kawakami Y (2009). Cancer metastasis is accelerated through
immunosuppression during Snail-induced EMT of cancer cells. Cancer cell 15: 195-206.
Kurpakus MA, Stock EL and Jones JC (1992). The role of the basement membrane in differential
expression of keratin proteins in epithelial cells. Developmental biology 150: 243-255.
LaGamba D, Nawshad A and Hay ED (2005). Microarray analysis of gene expression during epithelialmesenchymal transformation. Dev Dyn 234: 132-42.
Lan Y, Ryan RC, Zhang Z, Bullard SA, Bush JO, Maltby KM, Lidral AC and Jiang R (2006). Expression
of Wnt9b and activation of canonical Wnt signaling during midfacial morphogenesis in mice. Dev
Dyn 235: 1448-54.
Lan Y, Xu J and Jiang R (2015). Cellular and Molecular Mechanisms of Palatogenesis. Curr Top Dev
Biol 115: 59-84.
LaPierre DP, Lee DY, Li S-Z, Xie Y-Z, Zhong L, Sheng W, Deng Z and Yang BB (2007). The ability of
versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Research 67: 47424750.
Li G, Fox J, Liu Z, Liu J, Gao GF, Jin Y, Gao H and Wu M (2013). Lyn mitigates mouse airway
remodeling by downregulating the TGF-β3 isoform in house dust mite models. The Journal of
Immunology 191: 5359-5370.
Li M, Gu Y, Ma Y-C, Shang Z-F, Wang C, Liu F-J, Cao J-P, Wan H-J and Zhang X-G (2015). KrüppelLike Factor 5 Promotes Epithelial Proliferation and DNA Damage Repair in the Intestine of
Irradiated Mice. International journal of biological sciences 11: 1458.
Lim YJ, Koo JE, Hong E-H, Park Z-Y, Lim K-M, Bae O-N and Lee JY (2015). A Src-family-tyrosine
kinase, Lyn, is required for efficient IFN-β expression in pattern recognition receptor, RIG-I,
signal pathway by interacting with IPS-1. Cytokine 72: 63-70.
Love MI, Huber W and Anders S (2014). Moderated estimation of fold change and dispersion for RNAseq data with DESeq2. Genome Biol 15: 550.

76
Lu H, Jin Y and Tipoe GL (2000). Alteration in the expression of bone morphogenetic protein-2,3,4,5
mRNA during pathogenesis of cleft palate in BALB/c mice. Arch Oral Biol 45: 133-40.
Malin D, Petrovic V, Strekalova E, Sharma B and Cryns VL (2016). αB-crystallin: Portrait of a malignant
chaperone as a cancer therapeutic target. Pharmacology & therapeutics 160: 1-10.
Manzow S, Brancolini C, Marks F and Richter KH (1996). Expression of growth arrest-specific (Gas)
genes in murine keratinocytes: Gas2 is specifically regulated. Experimental cell research 224:
200-203.
Marazita ML and Mooney MP (2004). Current concepts in the embryology and genetics of cleft lip and
cleft palate. Clin Plast Surg 31: 125-40.
Marguerat S and Bahler J (2010). RNA-seq: from technology to biology. Cell Mol Life Sci 67: 569-79.
Martinez-Alvarez C, Blanco MJ, Perez R, Rabadan MA, Aparicio M, Resel E, Martinez T and Nieto MA
(2004). Snail family members and cell survival in physiological and pathological cleft palates.
Dev Biol 265: 207-18.
Matsushima S and Ishiyama J (2016). MicroRNA-29c regulates apoptosis sensitivity via modulation of
the cell-surface death receptor, Fas, in lung fibroblasts. American Journal of Physiology-Lung
Cellular and Molecular Physiology 311: L1050-L1061.
Medici D, Hay ED and Goodenough DA (2006). Cooperation between snail and LEF-1 transcription
factors is essential for TGF-β1-induced epithelial-mesenchymal transition. Molecular biology of
the cell 17: 1871-1879.
Medio M, Yeh E, Popelut A, Babajko S, Berdal A and Helms JA (2012). Wnt/β-catenin signaling and
Msx1 promote outgrowth of the maxillary prominences. Frontiers in physiology 3.
Meng L, Bian Z, Torensma R and Von den Hoff JW (2009). Biological mechanisms in palatogenesis and
cleft palate. J Dent Res 88: 22-33.
Miettinen PJ, Chin JR, Shum L, Slavkin HC, Shuler CF, Derynck R and Werb Z (1999). Epidermal
growth factor receptor function is necessary for normal craniofacial development and palate
closure. Nat Genet 22: 69-73.

77
Mir H, Meena AS, Chaudhry KK, Shukla PK, Gangwar R, Manda B, Padala MK, Shen L, Turner JR and
Dietrich P (2016a). Occludin deficiency promotes ethanol-induced disruption of colonic epithelial
junctions, gut barrier dysfunction and liver damage in mice. Biochimica et Biophysica Acta
(BBA)-General Subjects 1860: 765-774.
Mir H, Meena AS, Chaudhry KK, Shukla PK, Gangwar R, Manda B, Padala MK, Shen L, Turner JR,
Dietrich P, Dragatsis I and Rao R (2016b). Occludin deficiency promotes ethanol-induced
disruption of colonic epithelial junctions, gut barrier dysfunction and liver damage in mice.
Biochim Biophys Acta 1860: 765-74.
Miyazaki A, Ohkubo T, Hatta M, Ishikawa H and Yamazaki J (2015). Integrin α6β4 and TRPV1 channel
coordinately regulate directional keratinocyte migration. Biochemical and biophysical research
communications 458: 161-167.
Murray JC (2002). Gene/environment causes of cleft lip and/or palate. Clin Genet 61: 248-56.
Naranjo MC, Garcia I, Bermudez B, Lopez S, Cardelo MP, Abia R, Muriana FJ and Montserrat‐de la Paz
S (2016). Acute effects of dietary fatty acids on osteclastogenesis via RANKL/RANK/OPG
system. Molecular nutrition & food research 60: 2505-2513.
Nawshad A (2008). Palatal seam disintegration: to die or not to die? that is no longer the question. Dev
Dyn 237: 2643-56.
Nawshad A and Hay ED (2003). TGFbeta3 signaling activates transcription of the LEF1 gene to induce
epithelial mesenchymal transformation during mouse palate development. J Cell Biol 163: 1291301.
Nawshad A, LaGamba D and Hay ED (2004). Transforming growth factor beta (TGFbeta) signalling in
palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol 49:
675-89.
Nawshad A, Lagamba D, Polad A and Hay ED (2005). Transforming growth factor-beta signaling during
epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis.
Cells, tissues, organs 179: 11-23.

78
Nawshad A, Medici D, Liu CC and Hay ED (2007). TGFbeta3 inhibits E-cadherin gene expression in
palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell
Sci 120: 1646-53.
Nelms BL and Labosky PA (2010). Transcriptional control of neural crest development. Developmental
Biology 1: 1-227.
Nie X, Luukko K and Kettunen P (2006). BMP signalling in craniofacial development. Int J Dev Biol 50:
511-21.
Obholz KL, Akopyan A, Waymire KG and MacGregor GR (2006). FNDC3A is required for adhesion
between spermatids and Sertoli cells. Developmental biology 298: 498-513.
Okamoto N, Del Maestro R, Valero R, Monros E, Poo P, Kanemura Y and Yamasaki M (2004).
Hydrocephalus and Hirschsprung’s disease with a mutation of L1CAM. Journal of human
genetics 49: 334-337.
Orioli D, Henkemeyer M, Lemke G, Klein R and Pawson T (1996). Sek4 and Nuk receptors cooperate in
guidance of commissural axons and in palate formation. The EMBO Journal 15: 6035.
Ozturk F, Li Y, Zhu X, Guda C and Nawshad A (2013). Systematic analysis of palatal transcriptome to
identify cleft palate genes within TGFbeta3-knockout mice alleles: RNA-Seq analysis of
TGFbeta3 Mice. BMC Genomics 14: 113.
Panamonta V, Pradubwong S, Panamonta M and Chowchuen B (2015). Global birth prevalence of
orofacial clefts: a systematic review. J Med Assoc Thai 98: S11-21.
Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS,
Kirby RS and Correa A (2010). Updated National Birth Prevalence estimates for selected birth
defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88: 1008-16.
Patro R, Duggal G, Love MI, Irizarry RA and Kingsford C (2017). Salmon provides fast and bias-aware
quantification of transcript expression. Nat Methods 14: 417-419.

79
Paul B, Palmer K, Sharp J, Pratt C, Murray S and Dunnwald M (2017). ARHGAP29 Mutation Is
Associated with Abnormal Oral Epithelial Adhesions. Journal of Dental Research:
0022034517726079.
Pearton DJ, Smith CS, Redgate E, van Leeuwen J, Donnison M and Pfeffer PL (2014). Elf5 counteracts
precocious trophoblast differentiation by maintaining Sox2 and 3 and inhibiting Hand1
expression. Developmental biology 392: 344-357.
Porcionatto MA (2006). The extracellular matrix provides directional cues for neuronal migration during
cerebellar development. Brazilian journal of medical and biological research 39: 313-320.
Potts JR and Campbell ID (1996). Structure and function of fibronectin modules. Matrix Biology 15: 313320.
Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MW and
Doetschman T (1995). Transforming growth factor-beta 3 is required for secondary palate fusion.
Nat Genet 11: 409-14.
Puri P and Shinkai T (2004). Pathogenesis of Hirschsprung’s disease and its variants: recent progress.
Seminars in pediatric surgery. Elsevier, pp. 18-24.
Rabadan-Diehl C and Nathanielsz P (2013). From Mice to Men: research models of developmental
programming. Journal of developmental origins of health and disease 4: 3-9.
Ramdas V, McBride M, Denby L and Baker AH (2013). Canonical transforming growth factor-beta
signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR29. Am J Pathol 183: 1885-96.
Risley M, Garrod D, Henkemeyer M and McLean W (2009a). EphB2 and EphB3 forward signalling are
required for palate development. Mech Dev 126: 230-9.
Risley M, Garrod D, Henkemeyer M and McLean W (2009b). EphB2 and EphB3 forward signalling are
required for palate development. Mechanisms of development 126: 230-239.
Roberts A, Pimentel H, Trapnell C and Pachter L (2011). Identification of novel transcripts in annotated
genomes using RNA-Seq. Bioinformatics 27: 2325-2329.

80
Roberts ME, Bishop JL, Fan X, Beer JL, Kum WW, Krebs DL, Huang M, Gill N, Priatel JJ and Finlay
BB (2014). Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and
susceptibility to enteric pathogens. The Journal of Immunology 193: 5249-5263.
Sales KU, Friis S, Konkel JE, Godiksen S, Hatakeyama M, Hansen KK, Rogatto SR, Szabo R, Vogel LK
and Chen W (2015). Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant
progression and potentiation of ras-mediated squamous cell carcinogenesis. Oncogene 34: 346.
Satokata I and Maas R (1994). Msx1 deficient mice exhibit cleft palate and abnormalities of craniofacial
and tooth development. Nat Genet 6: 348-56.
Scardigli R, Soddu S, Falcioni R, Crescenzi M, Cimino L and Sacchi A (1996). The β 4 Integrin Subunit
Is Expressed in Mouse Fibroblasts and Modulated by Transforming Growth Factor-β 1.
Experimental cell research 227: 223-229.
Schäfer MK and Altevogt P (2010). L1CAM malfunction in the nervous system and human carcinomas.
Cellular and molecular life sciences 67: 2425-2437.
Schutte BC and Murray JC (1999). The many faces and factors of orofacial clefts. Hum Mol Genet 8:
1853-9.
Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng P-S, Wu Y, Lee V, Slingerland J and Dumont D
(2005). The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Molecular
biology of the cell 16: 1330-1340.
Smane L and Pilmane M (2016). Osteopontin, osteocalcin, and osteoprotegerin expression in human
tissue affected by cleft lip and palate. SHS Web of Conferences. EDP Sciences.
Smith PG, Tanaka H and Chantry A (2012). A novel co-operative mechanism linking TGFβ and Lyn
kinase activation to imatinib resistance in chronic myeloid leukaemia cells. Oncotarget 3: 518.
Sneath P (1973). Numerical taxonomy; the principles and practice of numerical classification, W. H.
Freeman: San Francisco, CA USA.

81
Snyder JM, Washington IM, Birkland T, Chang MY and Frevert CW (2015). Correlation of versican
expression, accumulation, and degradation during embryonic development by quantitative
immunohistochemistry. Journal of Histochemistry & Cytochemistry 63: 952-967.
Sonnesen L, Nolting D, Kjaer KW and Kjaer I (2008). Association between the development of the body
axis and the craniofacial skeleton studied by immunohistochemical analyses using collagen II,
Pax9, Pax1, and Noggin antibodies. Spine 33: 1622-1626.
Soofi A, Wolf KI, Emont MP, Qi N, Martinez-Santibanez G, Grimley E, Ostwani W and Dressler GR
(2017). The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and
metabolic syndrome in mice. Journal of Biological Chemistry 292: 9051-9062.
Spritz RA (2001). The genetics and epigenetics of orofacial clefts. Curr Opin Pediatr 13: 556-60.
Su HY, Lai HC, Lin YW, Chou YC, Liu CY and Yu MH (2009). An epigenetic marker panel for
screening and prognostic prediction of ovarian cancer. International journal of cancer 124: 387393.
Sun D, Vanderburg CR, Odierna GS and Hay ED (1998). TGFbeta3 promotes transformation of chicken
palate medial edge epithelium to mesenchyme in vitro. Development 125: 95-105.
Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and
Pachter L (2012). Differential gene and transcript expression analysis of RNA-seq experiments
with TopHat and Cufflinks. Nat Protoc 7: 562-78.
Vandenberg P, Khillan JS, Prockop DJ, Helminen H, Kontusaari S and Ala-Kokko L (1991). Expression
of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a
chondrodysplasia. Proc Natl Acad Sci U S A 88: 7640-4.
Vanhoutteghem A, Maciejewski-Duval A, Bouche C, Delhomme B, Hervé F, Daubigney F, Soubigou G,
Araki M, Araki K and Yamamura K-i (2009). Basonuclin 2 has a function in the multiplication of
embryonic craniofacial mesenchymal cells and is orthologous to disco proteins. Proceedings of
the National Academy of Sciences 106: 14432-14437.

82
Vogt J, Morgan NV, Rehal P, Faivre L, Brueton LA, Becker K, Fryns JP, Holder S, Islam L, Kivuva E,
Lynch SA, Touraine R, Wilson LC, MacDonald F and Maher ER (2012). CHRNG genotypephenotype correlations in the multiple pterygium syndromes. J Med Genet 49: 21-6.
Wang Z, Gerstein M and Snyder M (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev
Genet 10: 57-63.
Wegrowski Y, Perreau C, Martiny L, Haye B, Maquart F and Bellon G (1999). Transforming growth
factor β-1 Up-regulates clusterin synthesis in thyroid epithelial cells. Experimental cell research
247: 475-483.
Weston WM, Freeman AB, Haberecht C, Hackmiller RC, Ma L, Nugent P, Warr E, Pisano MM and
Greene RM (2002). Phosphatase regulation of gene expression during development of the palate.
Life sciences 71: 1849-1862.
Wodarz A and Nusse R (1998). Mechanisms of Wnt signaling in development. Annual review of cell and
developmental biology 14: 59-88.
Wu D, Mandal S, Choi A, Anderson A, Prochazkova M, Perry H, Gil-Da-Silva-Lopes VL, Lao R, Wan E
and Tang PL-F (2015). DLX4 is associated with orofacial clefting and abnormal jaw
development. Human molecular genetics 24: 4340-4352.
Xue T-C, Ge N-L, Zhang L, Cui J-F, Chen R-X, You Y, Ye S-L and Ren Z-G (2014). Goosecoid
promotes the metastasis of hepatocellular carcinoma by modulating the epithelial-mesenchymal
transition. PloS one 9: e109695.
Yamaguchi TP, Bradley A, McMahon AP and Jones S (1999). A Wnt5a pathway underlies outgrowth of
multiple structures in the vertebrate embryo. Development 126: 1211-1223.
Young MD, Wakefield MJ, Smyth GK and Oshlack A (2010). Gene ontology analysis for RNA-seq:
accounting for selection bias. Genome biology 11: R14.
Yu W, Kamara H and Svoboda KK (2008). The role of twist during palate development. Dev Dyn 237:
2716-25.

83
Yuan H, Kajiyama H, Ito S, Chen D, Shibata K, Hamaguchi M, Kikkawa F and Senga T (2015).
HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in
ovarian cancer cells. Oncotarget 6: 13359.
Zehnder AF, Kristiansen AG, Adams JC, Kujawa SG, Merchant SN and McKenna MJ (2006).
Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and
progressive hearing loss. The Laryngoscope 116: 201-206.
Zhang W-n, Li W, Wang X-l, Hu Z, Zhu D, Ding W-c, Liu D, Li K-z, Ma D and Wang H (2016). CLDN1
expression in cervical cancer cells is related to tumor invasion and metastasis. Oncotarget 7:
87449.
Zhang Z, Song Y, Zhao X, Zhang X, Fermin C and Chen Y (2002). Rescue of cleft palate in Msx1deficient mice by transgenic Bmp4 reveals a network of BMP and Shh signaling in the regulation
of mammalian palatogenesis. Development 129: 4135-4146.
Zhao J, Wu W, Zhang W, Lu YW, Tou E, Ye J, Gao P, Jourd'heuil D, Singer HA and Wu M (2017).
Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGFβ1/SMAD and myocardin/serum response factor. The FASEB Journal 31: 2576-2591.
Zhu X, Ozturk F, Liu C, Oakley GG and Nawshad A (2012a). Transforming growth factor-beta activates
c-Myc to promote palatal growth. J Cell Biochem 113: 3069-85.
Zhu X, Ozturk F, Pandey S, Guda CB and Nawshad A (2012b). Implications of TGFbeta on
Transcriptome and Cellular Biofunctions of Palatal Mesenchyme. Frontiers in physiology 3: 85.

84
Appendix A: Calculation Fold Change (Ratio) Using Cq Differences.
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